<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><?properties manuscript?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-journal-id">0372612</journal-id><journal-id journal-id-type="pubmed-jr-id">3129</journal-id><journal-id journal-id-type="nlm-ta">Compr Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Compr Psychiatry</journal-id><journal-title-group><journal-title>Comprehensive psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0010-440X</issn><issn pub-type="epub">1532-8384</issn></journal-meta><article-meta><article-id pub-id-type="pmid">40479924</article-id><article-id pub-id-type="pmc">12584586</article-id><article-id pub-id-type="doi">10.1016/j.comppsych.2025.152603</article-id><article-id pub-id-type="manuscript">NIHMS2112058</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>The LEADING guideline: Reporting standards for expert panel, best-estimate diagnosis, and longitudinal expert all data (LEAD) methods</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Eijsbroek</surname><given-names>Veerle C.</given-names></name><xref rid="A1" ref-type="aff">a</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Kjell</surname><given-names>Katarina</given-names></name><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Andrew Schwartz</surname><given-names>H.</given-names></name><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Boehnke</surname><given-names>Jan R.</given-names></name><xref rid="A3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name><surname>Fried</surname><given-names>Eiko I.</given-names></name><xref rid="A4" ref-type="aff">d</xref></contrib><contrib contrib-type="author"><name><surname>Klein</surname><given-names>Daniel N.</given-names></name><xref rid="A5" ref-type="aff">e</xref></contrib><contrib contrib-type="author"><name><surname>Gustafsson</surname><given-names>Peik</given-names></name><xref rid="A6" ref-type="aff">f</xref></contrib><contrib contrib-type="author"><name><surname>Augenstein</surname><given-names>Isabelle</given-names></name><xref rid="A7" ref-type="aff">g</xref></contrib><contrib contrib-type="author"><name><surname>Bossuyt</surname><given-names>Patrick M.M.</given-names></name><xref rid="A8" ref-type="aff">h</xref></contrib><contrib contrib-type="author"><name><surname>Kjell</surname><given-names>Oscar N.E.</given-names></name><xref rid="A1" ref-type="aff">a</xref></contrib></contrib-group><aff id="A1"><label>a</label>Department of Psychology, Lund University, Lund, Sweden</aff><aff id="A2"><label>b</label>Department of Computer Science, Stony Brook University, New York, United States</aff><aff id="A3"><label>c</label>School of Health Sciences, University of Dundee, Dundee, UK</aff><aff id="A4"><label>d</label>Institute of Psychology, Leiden University, Leiden, the Netherlands</aff><aff id="A5"><label>e</label>Department of Psychology, Stony Brook University, New York, United States</aff><aff id="A6"><label>f</label>Faculty of Medicine, Lund University, Lund, Sweden</aff><aff id="A7"><label>g</label>Department of Computer Science, University of Copenhagen, Copenhagen, Denmark</aff><aff id="A8"><label>h</label>Department of Epidemiology and Data Science, Amsterdam University Medical Centers, Amsterdam, the Netherlands</aff><author-notes><corresp id="CR1"><label>*</label>Corresponding author at: Allhelgona kyrkogata 16a, 223 62 Lund, Sweden. <email>veerle.eijsbroek@psy.lu.se</email> (V.C. Eijsbroek).</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>8</day><month>10</month><year>2025</year></pub-date><pub-date pub-type="ppub"><month>8</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>13</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>04</day><month>11</month><year>2025</year></pub-date><volume>141</volume><fpage>152603</fpage><lpage>152603</lpage><permissions><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the CC BY license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract id="ABS1"><p id="P1">Accurate assessments of symptoms and illnesses are essential for health research and clinical practice but face many challenges. The absence of a single error-free measure is currently addressed by assessment methods involving experts reviewing several sources of information to achieve a <italic toggle="yes">best-estimate assessment</italic>. This assessment method is called the <italic toggle="yes">Expert Panel</italic> method in medicine, and the <italic toggle="yes">Best-Estimate Diagnosis</italic> or <italic toggle="yes">Longitudinal Expert All Data</italic> (LEAD) method in psychiatry and psychology. However, due to poor reporting of the assessment methods, the quality of pro-claimed best-estimate assessments is typically difficult to evaluate, and when the method is reported, the reporting quality varies substantially. To tackle this gap, we have developed a reporting guideline following a four-stage approach: 1) drafting reporting standards accompanied by empirical evidence, which were further developed with a patient organization for depression, 2) incorporating expert feedback through a two-round Delphi procedure, 3) refining the guideline based on an expert consensus meeting, and 4) testing the guideline by i) having researchers test it and ii) applying it to previously published studies. The last step also provides evidence for the need for the guideline: 10&#x02013;63 % (Mean 33 %) of the standards were not reported across thirty randomly selected published studies. The result is the LEADING guideline comprising 20 reporting standards in four groups: the <italic toggle="yes">Longitudinal design</italic>, the <italic toggle="yes">Appropriate data</italic>, the <italic toggle="yes">Evaluation</italic> &#x02013; <italic toggle="yes">experts, materials and procedures</italic>, and the <italic toggle="yes">Validity</italic> group. We hope that the LEADING guideline will assist researchers in planning, conducting, reporting, and evaluating research aiming to achieve best-estimate assessments.</p></abstract><kwd-group><kwd>Reporting</kwd><kwd>Assessment</kwd><kwd>Expert panel</kwd><kwd>Longitudinal Expert All Data</kwd><kwd>Best-estimate diagnosis</kwd><kwd>Standard</kwd><kwd>Psychiatry</kwd></kwd-group></article-meta></front><body><sec id="S1"><label>1.</label><title>Introduction</title><p id="P2">Establishing valid and reliable assessments of symptoms and diagnoses is the foundation of health and clinical sciences. Given that reliable biological markers or specific objective signs for most mental health problems are lacking and many medical conditions only show objective markers in late stages, accurate assessments are difficult [<xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R2" ref-type="bibr">2</xref>]. Essentially, every single measure of a psychological construct has some potential source of bias (e.g., self-report and recall bias) or can be seen as fallible in some respect [<xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R4" ref-type="bibr">4</xref>] &#x02013; which can result in inaccurate assessments and delayed treatments.</p><p id="P3">The absence of a single error-free measure can be addressed by involving multiple experts reviewing several sources of information to form a <italic toggle="yes">best-estimate assessment</italic> or a reference standard [<xref rid="R5" ref-type="bibr">5</xref>&#x02013;<xref rid="R7" ref-type="bibr">7</xref>]. To understand the quality of such an assessment, it is crucial to understand how it was reached (i.e., the quality of the specific assessment method used). However, the quality of best-estimate assessments is typically very difficult to evaluate due to poor reporting of the assessment method, and when the method is reported, the reporting quality varies substantially [<xref rid="R7" ref-type="bibr">7</xref>]. Here, we tackle this problem by developing a guideline for how to report assessment methods that aim to achieve such best-estimate assessments, i.e., where experts review several sources of (longitudinal) information to achieve a more accurate assessment than a single, error-prone measure.</p><sec id="S2"><label>1.1.</label><title>Assessment</title><p id="P4"><italic toggle="yes">Assessment</italic> includes the evaluation, integration, and interpretation of several sources of information (e.g., outcomes of different measures, tests, or scans) to derive a valid and reliable decision (e.g., a best-estimate diagnosis) [<xref rid="R8" ref-type="bibr">8</xref>]. Accurate assessments are crucial. In clinical practice, under- or over-estimation of illnesses can have severe negative impacts on people's lives. In research, inaccurate assessments threaten the validity of scientific results. For policy and implementation development, assessments are the basis for guideline development and the economic and societal evaluations of interventions. Furthermore, obtaining more accurate assessments has become increasingly important considering that high-accuracy assessments are needed in diverse fields such as Biological Psychiatry (e.g., to find reliable biomarkers linked to reference standard assessments [<xref rid="R9" ref-type="bibr">9</xref>&#x02013;<xref rid="R11" ref-type="bibr">11</xref>]) and Artificial Intelligence (e.g., to train models to reference standard assessments [<xref rid="R12" ref-type="bibr">12</xref>&#x02013;<xref rid="R14" ref-type="bibr">14</xref>]).</p></sec><sec id="S3"><label>1.2.</label><title>A methodological solution</title><p id="P5">Here, we connect three bodies of literature that have proposed similar assessment methods: <italic toggle="yes">The Expert Panel</italic> method in medicine [<xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R16" ref-type="bibr">16</xref>] &#x02013; as well as the <italic toggle="yes">Best-Estimate Diagnosis</italic> [<xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R17" ref-type="bibr">17</xref>] and the <italic toggle="yes">Longitudinal Expert All Data</italic> (LEAD [<xref rid="R5" ref-type="bibr">5</xref>]) methods in clinical psychology and psychiatry. The three methods share the same goal of attaining best-estimate assessments through similar methodological approaches: All three methods use expert panels or consensus teams (e.g., clinical psychologists or medical doctors) to review several sources of information (e.g., clinical questionnaires and medical tests) to establish a more accurate assessment (e.g., a best-estimate diagnosis).</p><p id="P6">The <italic toggle="yes">Best-Estimate Diagnosis</italic> method was introduced by Leckman et al. [<xref rid="R6" ref-type="bibr">6</xref>] as a strategy to set accurate lifetime psychiatric diagnoses. The method focuses on two components, namely 1) using <italic toggle="yes">all data</italic> (e.g., information from medical records and relatives in addition to interviews) that is 2) evaluated by <italic toggle="yes">expert clinicians</italic> (who review all data and then reach a consensus [<xref rid="R17" ref-type="bibr">17</xref>]). Consequently, Spitzer [<xref rid="R5" ref-type="bibr">5</xref>] proposed the <italic toggle="yes">Longitudinal Expert All Data</italic> (LEAD) method to obtain a criterion or reference standard to validate the Diagnostic Interview Schedule [<xref rid="R18" ref-type="bibr">18</xref>] for setting psychiatric diagnoses. LEAD extends the Best-Estimate Diagnosis method and involves three essential components, namely <italic toggle="yes">Longitudinal</italic> data collection (i.e., not limited to a single examination at one point in time), <italic toggle="yes">Expert</italic> evaluation (i.e., the diagnoses are set by expert clinicians), and <italic toggle="yes">All Data</italic> (i.e., the experts have access to multiple data sources). A similar approach was proposed in medicine, where the <italic toggle="yes">Expert Panel</italic> method was developed as a solution for diagnostic accuracy studies with an imperfect or missing reference standard [<xref rid="R16" ref-type="bibr">16</xref>,<xref rid="R19" ref-type="bibr">19</xref>,<xref rid="R20" ref-type="bibr">20</xref>]. Here, a <italic toggle="yes">panel of experts</italic> decides on a medical condition based on <italic toggle="yes">all relevant information</italic>. A review of expert panel studies [<xref rid="R7" ref-type="bibr">7</xref>] identified four critical components of the expert panel design, namely 1) the panel constitution, 2) the information presented to the panel, 3) the decision process of the panel, and 4) the validity of the panel diagnosis.</p><p id="P7">So, all three methods employ a similar approach to obtain <italic toggle="yes">best-estimate assessments</italic> (e.g., for diagnostic purposes or as a reference standard) while accentuating parts of it: The Best-Estimate Diagnosis method accentuates the use of informants and objective tests next to self-reported data [<xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R17" ref-type="bibr">17</xref>]; the Expert Panel method focuses on the characteristics, constitution, and procedure of the panel [<xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R15" ref-type="bibr">15</xref>] and only the LEAD method requires a longitudinal design [<xref rid="R5" ref-type="bibr">5</xref>], although longitudinal data are also used in some Expert Panel designs (&#x02248;27 % of studies [<xref rid="R7" ref-type="bibr">7</xref>]). Herein, we collectively refer to these three approaches as the <italic toggle="yes">assessment methods</italic>.</p><p id="P8">The result of the <italic toggle="yes">assessment methods</italic> is a consensually derived criterion (e.g., a best-estimate assessment) that has been used for many different applications where there is no single error-free measure. It has, for example, been used to i) evaluate the accuracy of a measurement tool or marker through comparison to a best-estimate assessment [<xref rid="R21" ref-type="bibr">21</xref>&#x02013;<xref rid="R26" ref-type="bibr">26</xref>]; ii) establish the prevalence of symptoms and disorders [<xref rid="R27" ref-type="bibr">27</xref>&#x02013;<xref rid="R29" ref-type="bibr">29</xref>]; iii) establish the temporal stability or development of symptoms and disorders [<xref rid="R30" ref-type="bibr">30</xref>&#x02013;<xref rid="R32" ref-type="bibr">32</xref>]; iv) improve (earlier) detection or screening of symptoms or disorders [<xref rid="R33" ref-type="bibr">33</xref>&#x02013;<xref rid="R35" ref-type="bibr">35</xref>]; v) study genetics and family history [<xref rid="R36" ref-type="bibr">36</xref>&#x02013;<xref rid="R38" ref-type="bibr">38</xref>]; and vi) examine classification systems or diagnostic criteria [<xref rid="R39" ref-type="bibr">39</xref>&#x02013;<xref rid="R41" ref-type="bibr">41</xref>]. The applications span diverse fields, including medicine, psychiatry, clinical psychology, public health/epidemiology, and artificial intelligence. <xref rid="BX1" ref-type="boxed-text">Box 1</xref> provides more examples of how the best-estimate assessments have been applied in different types of studies across fields.</p></sec><sec id="S4"><label>1.3.</label><title>Reporting issues</title><p id="P9">The assessment methods possess a high potential for achieving best-estimate reference standards in many situations. However, the quality of such proclaimed best-estimate assessments varies substantially and is typically very difficult to evaluate due to poor reporting of the method <italic toggle="yes">how</italic> they were achieved (e.g., see reviews of expert panels [<xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R15" ref-type="bibr">15</xref>]). A systematic review of assessment methods and reporting of expert panels [<xref rid="R7" ref-type="bibr">7</xref>] has demonstrated that the methods used for panel or consensus diagnoses vary substantially across studies and that many aspects of the procedure are often unclear or not reported at all (i.e., in 83 % of the reviewed studies). Many recent studies fail to report central aspects of the assessment procedures, including the quality, structure, or presentation of the data [<xref rid="R43" ref-type="bibr">43</xref>], the training and qualifications of the experts [<xref rid="R44" ref-type="bibr">44</xref>], the method for avoiding biases and achieving consensus [<xref rid="R45" ref-type="bibr">45</xref>], and the time span of the longitudinal design-component [<xref rid="R46" ref-type="bibr">46</xref>]. The poor operationalization of the assessment methods jeopardizes the goal of achieving best-estimate assessments &#x02013; where a vaguely described method makes it difficult to evaluate the research. Referring to an assessment as a <italic toggle="yes">best-estimate</italic> (and sometimes even as a <italic toggle="yes">gold standard</italic>) while vaguely describing or poorly operationalizing the method for achieving the assessment is alarming [<xref rid="R47" ref-type="bibr">47</xref>,<xref rid="R48" ref-type="bibr">48</xref>].</p></sec><sec id="S5"><label>1.4.</label><title>The degree of validity</title><p id="P10">These assessment methods aim to achieve high validity (i.e., the degree to which the assessment captures what it aims to measure). Typically, the assessment methods aim to achieve as high validity as possible (i.e., a &#x0201c;leading&#x0201d; assessment) or, depending on resources, at least more accurate than a single error-prone measure. Despite this central aim, research often fails to clearly describe the degree of validity of the attained assessment. Using these assessment methods does not automatically guarantee high validity &#x02013; it depends on how well the method is executed.</p><p id="P11">In addition, the derived assessments are often described with different terms: <italic toggle="yes">reference standard</italic> is often used in medicine, and <italic toggle="yes">criterion standard</italic> or <italic toggle="yes">best-estimate diagnosis</italic> is often used in psychology. We propose that the reporting of these assessment methods benefit from more explicitly describing <italic toggle="yes">what</italic> was measured and <italic toggle="yes">how</italic> well it measures up to different standards &#x02013; whether and how they relate to a state-of-the-art assessment. Whereas <italic toggle="yes">reference</italic> and <italic toggle="yes">criterion standards</italic> fail to convey an intention of &#x0201c;nearing&#x0201d; a state-of-the-art assessment, the <italic toggle="yes">best-estimate diagnosis</italic> narrowly focuses on the classification of a diagnosis and not on symptom severity. Therefore, we here use the term <italic toggle="yes">best-estimate assessment</italic> in the context of describing a &#x0201c;leading&#x0201d;, state-of-the-art assessment.</p></sec><sec id="S6"><label>1.5.</label><title>Reporting standards</title><p id="P12">Previous well-established guidelines have focused on the complete reporting of specific study designs, such as the <italic toggle="yes">STrengthening the Reporting of OBservational studies in Epidemiology</italic> (STROBE [<xref rid="R49" ref-type="bibr">49</xref>]) for observational studies; the <italic toggle="yes">Statement for Reporting for Diagnostic Accuracy</italic> (STARD [<xref rid="R50" ref-type="bibr">50</xref>]) for diagnostic accuracy studies; the <italic toggle="yes">Consolidated Standards of Reporting Trials</italic> (CONSORT [<xref rid="R51" ref-type="bibr">51</xref>]) for randomized trials, and the <italic toggle="yes">Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis</italic> (TRIPOD+AI [<xref rid="R52" ref-type="bibr">52</xref>]) for prediction model studies (see the <xref rid="SD1" ref-type="supplementary-material">supplementary material [SM]</xref> for other relevant guidelines). The STARD guidance is most closely related to the reporting of the assessment methods since best-estimate assessments are often used to evaluate a measure's (diagnostic) accuracy. However, none of the guidelines are sufficient for complete reporting of the assessment methods, where (multiple) experts review several sources of (longitudinal) information to form a best-estimate assessment. Although an earlier systematic review identified and structured the various choices involved in Expert Panel procedures [<xref rid="R7" ref-type="bibr">7</xref>], no attempt was made to develop a formal guideline for the reporting of Expert Panel assessments.</p></sec><sec id="S7"><label>1.6.</label><title>Aim</title><p id="P13">Our aim is to develop reporting standards for comprehensive reporting of Expert Panel, Best-Estimate Diagnosis, and LEAD methods &#x02013; which can help researchers plan and report studies employing these assessment methods, as well as help readers evaluate them. We call the reporting guideline the LEADING guideline, emphasizing the methodological components and the importance of describing <italic toggle="yes">what</italic> is assessed and <italic toggle="yes">how well</italic> (i.e., how it relates to a &#x0201c;leading&#x0201d; assessment). The individual reporting standards are divided into four groups according to the components of LEAD (<italic toggle="yes">Longitudinal, Expert, All Data</italic> [<xref rid="R5" ref-type="bibr">5</xref>]), from which we revised the original meanings to <italic toggle="yes">Longitudinal</italic>, <italic toggle="yes">Evaluation</italic> &#x02013; <italic toggle="yes">experts, materials and procedures</italic>, <italic toggle="yes">Appropriate Data</italic>, and <italic toggle="yes">Validity.</italic> In short, the LEADING guideline aims to guide the reporting of assessment method to improve evaluations of the assessment standard.</p></sec></sec><sec id="S8"><label>2.</label><title>Methods</title><p id="P14">We developed the reporting guideline over four stages: 1) drafting reporting standards, 2) incorporating expert feedback, 3) refining the final guideline, and 4) testing the guideline. The development method largely followed Moher and colleagues' guidance for developing reporting guidelines [<xref rid="R53" ref-type="bibr">53</xref>] (See <xref rid="SD1" ref-type="supplementary-material">Table S1</xref> for elaborations on each recommended step). For organizational purposes, a working group (V.E., K. K., &#x00026; O.K.) was set up, and a steering group (H.A.S., J.B., E.F., D.K., P.G., I.A., &#x00026; P.B.) was formed to provide a wide range of expertise. The steering group included seven experts and was selected to cover diverse expertise and fields related to the assessment methods (e.g., psychiatry/clinical psychology, medicine, epidemiology/public health, and Artificial Intelligence). Information regarding ethics is presented after the discussion.</p><sec id="S9"><label>2.1.</label><title>Drafting reporting standards</title><p id="P15">The working group, with the support of the steering group members, identified relevant research using or describing the assessment methods, including the three bodies of literature: Expert Panel [<xref rid="R7" ref-type="bibr">7</xref>], Best-Estimate Diagnosis [<xref rid="R6" ref-type="bibr">6</xref>], and LEAD [<xref rid="R5" ref-type="bibr">5</xref>]. In addition, articles using any of the three assessment methods were identified through a literature search using Google Scholar with the following search terms: [&#x0201c;expert panel diagnosis&#x0201d; OR &#x0201c;expert panel assessment&#x0201d; OR &#x0201c;expert panel consensus&#x0201d; OR &#x0201c;expert panel methodology&#x0201d; OR &#x0201c;expert panel standard&#x0201d; OR &#x0201c;expert panel reference&#x0201d;] for Expert Panel studies; [&#x0201c;best-estimate diagnosis&#x0201d; OR &#x0201c;best-estimate diagnostic&#x0201d; OR &#x0201c;best-estimate standard&#x0201d; OR &#x0201c;best-estimate assessment&#x0201d; OR &#x0201c;best-estimate methodology&#x0201d; OR &#x0201c;best-estimate reference&#x0201d;] for Best-Estimate Diagnosis studies; and [&#x0201c;longitudinal expert all data&#x0201d; OR &#x0201c;longitudinal evaluation all data&#x0201d;] for LEAD studies. Articles that clearly stated using one of the three assessment methods were selected. Articles stating another purpose than assessment (e.g. when an expert panel was used to reach a consensus about a treatment strategy) were excluded.</p><p id="P16">Furthermore, relevant reporting guidelines and systematic reviews were identified, including a review of expert panel applications [<xref rid="R7" ref-type="bibr">7</xref>], the STROBE statement [<xref rid="R54" ref-type="bibr">54</xref>], and the STARD guidance [<xref rid="R50" ref-type="bibr">50</xref>]. Other complementary reporting guidelines and systematic reviews are presented in the SM. The aim was for the reporting standards in the LEADING guideline to complement rather than repeat them (i.e., new standards should extend or complement existing standards rather than repeat them [<xref rid="R53" ref-type="bibr">53</xref>]). For example, when reporting a randomized trial that includes best-estimate assessments, one may use CONSORT [<xref rid="R55" ref-type="bibr">55</xref>] to report the trial design and main results, the LEADING guideline for describing the specifics for reaching the best-estimate assessments, and the <italic toggle="yes">Consolidated Health Economic Evaluation Reporting Standards</italic> (CHEERS) [<xref rid="R56" ref-type="bibr">56</xref>] for reporting the economic evaluations and comparisons.</p><p id="P17">Potential standards were drafted by the working group with the objective of encompassing a comprehensive reporting of the assessment methods. The reporting standards were grouped into four groups: <italic toggle="yes">Longitudinal design</italic>, <italic toggle="yes">Appropriate data</italic>, <italic toggle="yes">Evaluation</italic> &#x02013; <italic toggle="yes">experts, materials and procedures</italic>, and <italic toggle="yes">Validity</italic>. Empirical and theoretical inclusion rationales were stated for the groups and the individual standards (i.e., explanations and elaborations). Lastly, the standards with inclusion rationales were further developed through a workshop with a patient organization for depression, followed by feedback from the steering group members to receive a wide range of perspectives early in the process.</p></sec><sec id="S10"><label>2.2.</label><title>Incorporating expert feedback</title><p id="P18">To systematically collect expert feedback from different perspectives, we used a consensus-building procedure called the <italic toggle="yes">Delphi technique</italic> [<xref rid="R57" ref-type="bibr">57</xref>]. We used an iterative process based on two rounds of questionnaires (i.e., Delphi surveys), enabling feedback from round 1 to feed into round 2. Delphi participants received relevant background research, the reporting guideline aims, and the reporting standards with their inclusion rationales. They provided feedback through open- and closed-ended response formats. Through open-ended responses in Round 1, experts could propose new standards and provide feedback on the formulations of existing standards and their inclusion rationales. In addition, two closed-ended questions [<xref rid="R58" ref-type="bibr">58</xref>] about standard inclusion (<italic toggle="yes">This item should be included in the reporting checklist</italic>) and perception of study quality (<italic toggle="yes">Whether this information is present or not would influence my perceptions of the quality of a study</italic>) were answered with rating scales ranging from 1 = <italic toggle="yes">Strongly disagree</italic> to 7 = <italic toggle="yes">Strongly agree</italic>. In Round 2, the experts were asked to rate the updated reporting standards using the same two closed-ended questions as in Round 1 and to provide feedback on the clarifications and reformulations through open-ended responses.</p><p id="P19">To recruit Delphi participants, the first and/or last authors of articles since 2013 using any of the three assessment methods were identified using the search terms described above (<italic toggle="yes">n</italic> = 87 articles, <italic toggle="yes">n</italic> = 124 authors; see the <xref rid="SD1" ref-type="supplementary-material">SM</xref> for more details). These authors and the seven steering group members were invited via email to participate in the Delphi Round 1 (<italic toggle="yes">n</italic> = 131 participants emailed). In total, 27 participants completed the survey (response rate 21 %). Only participants from Round 1 who provided their contact details were invited to Round 2 (<italic toggle="yes">n</italic> = 25). In total, 20 participants completed the survey (response rate 80 %). All participants provided their informed consent. <xref rid="F1" ref-type="fig">Fig. 1</xref> presents the research experiences and demographics of the Delphi participants. Participants reported a wide range of academic backgrounds (e.g., Clinical Psychology, Psychiatry, Medicine, Artificial Intelligence, Journal Editors) and an extensive variety of relevant methodological experiences (e.g., Ecological Momentary Assessments, Biological Markers, and Expert Panels; <xref rid="F1" ref-type="fig">Fig. 1</xref>), with an age range of 30&#x02013;70 years (<italic toggle="yes">M</italic> = 51.54, <italic toggle="yes">SD</italic> = 12.40).</p><sec id="S11"><label>2.2.1.</label><title>Delphi survey results</title><p id="P20">The criteria for including a reporting standard was that the median of Delphi expert responses was at least <italic toggle="yes">6</italic> = <italic toggle="yes">Agree</italic> on the question about its inclusion. In Round 1, the mean ratings for the <italic toggle="yes">item inclusion</italic> scale ranged from 5.37 to 6.67 (<italic toggle="yes">M</italic> = 6.06; <italic toggle="yes">SD</italic> = 0.31; <xref rid="SD1" ref-type="supplementary-material">Table S2</xref>) with a median agreement ranging from <italic toggle="yes">6</italic> = <italic toggle="yes">Agree</italic> to <italic toggle="yes">7</italic> = <italic toggle="yes">Strongly Agree.</italic> No new standards were suggested. The feedback resulted in the removal of one reporting standard and the clarification and reformulation of 20 standards. The standard on <italic toggle="yes">Transparency and replicability</italic> was rated as relevant but removed because it is achieved by reporting the other reporting standards. Standard <italic toggle="yes">4.2 Validity and Standard</italic> needed a major clarification about the meaning of validity as well as standard. Minor clarifications and reformations, such as grammar or word changes, were made for 19 standards (see open material). The mean ratings in Round 2 ranged from 5.47 to 6.70 (<italic toggle="yes">M</italic> = 6.20; <italic toggle="yes">SD</italic> = 0.37; <xref rid="SD1" ref-type="supplementary-material">Table S3</xref>), with open feedback resulting in minor clarifications and reformulations of nine standards.</p></sec></sec><sec id="S12"><label>2.3.</label><title>Refining the guideline through expert consensus</title><p id="P21">The authors finalized the guidelines in an expert consensus meeting. The meeting was held online with nine working and steering group members. The content and structure of the consensus meeting were prepared by the working group, and the meeting was led by the last author (O.K.). Participants had access to the guidelines, inclusion rationales (i.e., elaboration and explanation), and the drafted paper before the meeting, where they also had the option to provide comments and feedback in writing. The meeting included reviewing the Delphi Rounds 1 and 2 findings and discussing the paper draft, including the individual reporting standards and groups. We decided not to carry out another Delphi round since i) the median agreement for each reporting standard in both Delphi Rounds 1 and 2 ranged from <italic toggle="yes">6</italic> = <italic toggle="yes">Agree</italic> to <italic toggle="yes">7</italic> = <italic toggle="yes">Strongly Agree</italic>, ii) no new standards were suggested, and iii) only minor changes were needed after Round 2, which taken together suggest consensus.</p></sec><sec id="S13"><label>2.4.</label><title>Testing the guideline</title><p id="P22">To test the applicability of the guideline, the guideline was tested i) by independent researchers with experience of each method piloting the reporting of each standard and ii) by the authors (V.E., K.K.) applying it to published articles. The two test procedures resulted in adding minor clarifications to three standards (<italic toggle="yes">2.4 The access to the index measure, 3.3 Blindness and conflict of interest,</italic> and <italic toggle="yes">3.4 Instructions and training</italic>). Also, a concrete example of how to report the items was added to the guideline instructions.</p><sec id="S14"><label>2.4.1.</label><title>Incorporating test-user feedback</title><p id="P23">Two test users (PhD, with experience using the LEAD and Expert Panel method) who had not been involved in the development of the guideline (e.g., in the Delphi procedure) were recruited to pilot the guideline (see the <xref rid="SD1" ref-type="supplementary-material">SM</xref> for more details). They were asked to report each standard based on a finished, ongoing or planned study using one of the assessment methods and/or provide feedback about the formulation of the standards.</p></sec><sec id="S15"><label>2.4.2.</label><title>Applying the standards to published studies</title><p id="P24">Three separate targeted searches (LEAD, Expert-panel, Best-estimate) were conducted using the search terms described above. The first author (V.E.) examined which standards were reported in 30 randomly selected articles applying the assessment methods in 2022 and 2023 (i. e., five from each method from each year; see the <xref rid="SD1" ref-type="supplementary-material">SM</xref> for the selection process). Each reporting standard was rated using four categories: standard <italic toggle="yes">not reported</italic>; standard <italic toggle="yes">reported vaguely or insufficiently</italic>; standard <italic toggle="yes">(minimally) sufficiently reported</italic>; or standard <italic toggle="yes">not applicable to the study</italic>. Out of the 30 articles, six were randomly selected (i.e., one from each method from each year) and examined by the second author (K.K.) to get insight into the accuracy of the ratings of the first author. Discussing their disagreements to reach consensus resulted in changing 23 ratings (19 %) of the first author. This testing procedure also provided information about the strengths and shortcomings of contemporary reporting of published articles using the assessment methods (see <xref rid="S16" ref-type="sec">Results</xref> section).</p></sec></sec></sec><sec id="S16"><label>3.</label><title>Results</title><p id="P25">The reporting guideline is presented in <xref rid="T1" ref-type="table">Table 1</xref> (see <xref rid="F2" ref-type="fig">Fig. 2</xref> for an overview). It comprises 20 standards for comprehensive reporting of the assessment methods divided into four groups: 1. <italic toggle="yes">The Longitudinal design</italic> group (4 standards), 2. <italic toggle="yes">The Appropriate data</italic> group (4 standards), 3. <italic toggle="yes">The Evaluation</italic> &#x02013; <italic toggle="yes">experts, materials, and procedures</italic> group (10 standards), and 4. <italic toggle="yes">The Validity</italic> group (2 standards). The reporting standards encourage researchers to elaborate on what was done and why &#x02013; whilst avoiding normative standards, such as a minimum number of experts. Each standard description in <xref rid="T1" ref-type="table">Table 1</xref> is accompanied by an example. Further <italic toggle="yes">Explanations and Elaborations</italic> regarding the individual reporting standards and the four groups are presented in the SM, including <xref rid="SD1" ref-type="supplementary-material">Tables S4</xref> and <xref rid="SD1" ref-type="supplementary-material">S5</xref>. A reporting template for providing an overview of the standard reports can be found on <ext-link xlink:href="http://www.leading-guideline.org/" ext-link-type="uri">www.leading-guideline.org</ext-link>.</p><sec id="S17"><label>3.1.</label><title>Applying the LEADING guideline to published studies</title><p id="P26">Applying the guideline to a random selection of 30 articles indicated severe heterogeneity in <italic toggle="yes">what</italic> of the methods is reported and <italic toggle="yes">how</italic> (<xref rid="T2" ref-type="table">Table 2</xref>; see the <xref rid="SD1" ref-type="supplementary-material">SM</xref> for the search strategy). Across the 30 studies, 10 to 63 % (Mean = 33 %) of the standards were <italic toggle="yes">not</italic> reported. Regarding the reporting standards, the type and quality of the data (2.1), the access to the index measure (2.4), the expert and panel characteristics (3.1), the number of experts and panels (3.2), the assessment procedure (3.5), and the assessment description (4.1) were mostly reported (i.e., green in more than 50 % of the studies). However, the data presentation (2.3), the instructions and training (3.4), the data combination method (3.7), the inter-rater and inter-panel reliability (3.9), and the validity and standard (4.2) were <italic toggle="yes">not</italic> reported at all in the majority of the studies (i.e., red in more than 50 % of the studies). Considering that most changes that resulted from discussing disagreements between the raters (V.E. and K.K.) were from green to orange, and that green refers to a (minimally) sufficiently reported and orange to insufficiently reported, this suggests that the table is conservative in regards to the severity of the current state of poor reporting (i.e., potentially showing a more positive picture; for more information see the <xref rid="SD1" ref-type="supplementary-material">SM</xref>).</p></sec></sec><sec id="S18"><label>4.</label><title>Discussion</title><p id="P27">Our objective was to develop a guideline that supports comprehensive reporting of assessment methods collecting longitudinal, appropriate data that experts evaluate to achieve an assessment that is more accurate than a single error-prone measure. This assessment method is known as Expert Panel in medicine, and Best-Estimate Diagnosis or LEAD in psychiatry and clinical psychology. Given that reliable biological markers or specific objective signs are lacking not only in mental health but also in some medical conditions, the assessment approach&#x02014;and this guideline&#x02014;have wide applicability across diverse clinical domains (see <xref rid="BX1" ref-type="boxed-text">Box 1</xref>). The aim of the LEADING guideline is to help researchers plan, conduct, report, and evaluate the assessment method-related elements of this study design.</p><p id="P28">The LEADING reporting standards were established through an open process, incorporating relevant empirical evidence and methodological work, complementary reporting guidelines, and comprehensive iterations of expert feedback and patients' perspectives. As this guideline focuses on the assessment methods, we recommend that researchers also rely on established guidelines for other parts of their research, such as sampling and other epidemiological aspects (e.g., STROBE, CONSORT, and STARD).</p><sec id="S19"><label>4.1.</label><title>Limitations</title><p id="P29">We have connected three assessment methods with similar approaches from related fields and drafted applicable reporting standards. We presented the rationale for these three methods and each reporting standard with supporting evidence in the Delphi survey for review, which did not bring up additional methods or reporting standards. As we did not carry out a systematic literature review, we cannot exclude the existence of other assessment methods with similar approaches. We welcome any suggestions about similar methods to which the guideline is applicable.</p><p id="P30">The Delphi survey participants and the author group had a wide range of experiences and backgrounds; however, geographically, Europe and North America were the most common, whereas several areas were not represented. The Delphi participants were the first or last authors of studies employing the assessment methods. The quality of the articles and the education or experience of the authors were not taken into account as selection criteria (although it was self-reported, as presented in <xref rid="F1" ref-type="fig">Fig. 1</xref>). The number of Delphi participants (27 in Round 1, 20 in Round 2) is relatively small compared to some other standard developments (e. g., 73 in the development of STARD [<xref rid="R88" ref-type="bibr">88</xref>]) but comparable to others (e.g., 24 for the development of the TRIPOD statement [<xref rid="R89" ref-type="bibr">89</xref>]). Even though the response rate in Round 1 (21 %) can be considered low, the number of participants was sufficient to cover a broad range of academic backgrounds, methodological experiences, and demographics (<xref rid="F1" ref-type="fig">Fig. 1</xref>). The same limitation is applicable to the size of the steering group (<italic toggle="yes">n</italic> = 7) and the current test-user group (<italic toggle="yes">n</italic> = 2).</p></sec><sec id="S20"><label>4.2.</label><title>Implementation, adherence, and evolvement</title><sec id="S21"><label>4.2.1.</label><title>Implementation</title><p id="P31">We encourage implementation of and adherence to the LEADING guideline via <ext-link xlink:href="http://www.leading-guideline.org/" ext-link-type="uri">www.leading-guideline.org</ext-link>, scientific journals, editorials, commentaries, and the <italic toggle="yes">Enhancing the QUAlity and Transparency Of health Research</italic> (EQUATOR) Network (<ext-link xlink:href="http://www.equator-network.org/" ext-link-type="uri">www.equator-network.org</ext-link>). The LEADING guideline aims to support authors in writing their research reports, editors and peer reviewers in reviewing submitted reports, and readers in critically evaluating published reports. We encourage editors and publishers to support adherence to the LEADING guideline by referring to it in author guidelines. We recommend that authors submit the guideline as an appendix to their manuscripts (see <ext-link xlink:href="http://www.leading-guideline.org" ext-link-type="uri">www.leading-guideline.org</ext-link> for a reporting template). We also encourage dissemination of the guideline via inclusion in research seminars and method courses in clinical studies. Teaching early career researchers about the benefits of comprehensive reporting can promote adoption and adherence, for example, by requiring students to write theses in accordance with the applicable guideline. Further dissemination is encouraged by welcoming translations of the guideline into different languages.</p></sec><sec id="S22"><label>4.2.2.</label><title>Adherence</title><p id="P32">Reporting guidelines have become widely available for different study designs, especially in medicine. However, it is important to measure adherence to the guidelines, including identifying barriers and opportunities, and evaluate their impact on reporting quality [<xref rid="R90" ref-type="bibr">90</xref>,<xref rid="R91" ref-type="bibr">91</xref>]. Potential adherence barriers include prolonged reporting time, especially when multiple guidelines are needed for the report of the complete study design. However, standardized templates, as well as training and repeated practice, can increase efficiency and facilitate adherence [<xref rid="R90" ref-type="bibr">90</xref>,<xref rid="R91" ref-type="bibr">91</xref>]. We plan to measure adherence to the LEADING guideline via, for example, standardized adherence assessment forms [<xref rid="R92" ref-type="bibr">92</xref>] or AI-based tools that are currently being developed for determining reporting guideline compliance [<xref rid="R93" ref-type="bibr">93</xref>,<xref rid="R94" ref-type="bibr">94</xref>].</p></sec><sec id="S23"><label>4.2.3.</label><title>Evolvement</title><p id="P33">The LEADING guideline should be regarded as an evolving reporting guideline requiring ongoing evaluation, refinement, and revision. Methodological components of assessment methods evolve: The LEADING guideline will be periodically updated to correspond to the state-of-the-art of <italic toggle="yes">Expert Panel</italic>, <italic toggle="yes">Best-Estimate Diagnosis</italic>, and <italic toggle="yes">LEAD</italic> methods. We encourage readers to provide recommendations for improvements by emailing the corresponding author. Future modifications will be published on the website and aim to reflect feedback and new evidence, ultimately aiming to improve the reporting quality of the assessment methods.</p></sec></sec><sec id="S24"><label>4.3.</label><title>Conclusions</title><p id="P34">The LEADING guideline emphasizes the transparent reporting of the methodological components of Expert Panel, Best-Estimate Diagnosis, and LEAD designs and the importance of reporting <italic toggle="yes">what</italic> was assessed and <italic toggle="yes">how</italic> well. Considering the increasing need for high-accuracy assessments in diverse fields, we hope that the LEADING guideline will be useful in assisting researchers in planning, carrying out, reporting, and evaluating research that aims to achieve accurate assessments.</p></sec></sec><sec sec-type="supplementary-material" id="SM1"><title>Supplementary Material</title><supplementary-material id="SD1" position="float" content-type="local-data"><label>media-1.pdf</label><media xlink:href="NIHMS2112058-supplement-media-1_pdf.pdf" id="d67e988" position="anchor"/></supplementary-material><p id="P35">Appendix A. Supplementary data</p><p id="P36">The <xref rid="SD1" ref-type="supplementary-material">supplementary material</xref> includes 1) relevant and complementary reporting guidelines and systematic reviews, 2) elaboration on the steps for developing a health research reporting guideline (<xref rid="SD1" ref-type="supplementary-material">Table S1</xref>; Moher et al., 2010), 3) the search strategies for identifying articles using the assessments methods and for recruiting Delphi participants and test-users, 4) the closed-ended ratings for each reporting standard from the Delphi surveys (<xref rid="SD1" ref-type="supplementary-material">Tables S2</xref> and <xref rid="SD1" ref-type="supplementary-material">S3</xref>), 5) the explanation and elaboration for the reporting standards, including inclusion rationales and empirical evidence (<xref rid="SD1" ref-type="supplementary-material">Table S4</xref>), and 6) the procedure for applying the reporting standards to studies published in 2022 and 2023. <xref rid="SD1" ref-type="supplementary-material">Supplementary data</xref> to this article can be found online at [<ext-link xlink:href="10.1016/j.comppsych.2025.152603" ext-link-type="doi">https://doi.org/10.1016/j.comppsych.2025.152603</ext-link>].</p></sec></body><back><ack id="S25"><title>Acknowledgements</title><p id="P37">Patient organization members</p><p id="P38"><bold>E. Sellberg</bold> (Chairman of Libra Balans Sk&#x000e5;ne, board member of Balans National) and <bold>I. Odenbrand</bold> (Vice Chairman of Libra Balans Sk&#x000e5;ne).</p><p id="P39">Participants in Delphi Round 1.</p><p id="P40"><bold>I. Augenstein</bold> (Professor, Computer Science, University of Copenhagen), <bold>S. Aydin</bold> (PhD, Developmental and Educational Psychology, Leiden University), <bold>E. Billstedt</bold> (Professor, Neuroscience and Physiology, University of Gothenburg), <bold>J.R. Boehnke</bold> (PhD, School of Health Sciences, University of Dundee), <bold>D.W. Black</bold> (MD, Professor, Medicine, University of Iowa Carver College of Medicine), <bold>B. Cannell</bold> (Associate Professor, Public Health, University of Texas Health Science Center at Houston), <bold>G.A. Carlson</bold> (Professor, Psychiatry, Stony Brook University), <bold>K.A.S. Davis</bold> (Researcher, Psychiatry Psychology and Neuroscience, King's College London), <bold>F. Dereboy</bold> (MD, Psychiatry, Ayd&#x00131;n Adnan Menderes University), <bold>E.I. Fried</bold> (Associate Professor, Clinical Psychology, Leiden University), <bold>P. Gustafsson</bold> (Associate Professor, Child and Adolescent Psychiatry, Lund University), <bold>R. Handels</bold> (Assistant Professor, Psychiatry and Neuropsychology, Maastricht University), <bold>K. Jenniskens</bold> (Assistant Professor, Clinical Epidemiology, Utrecht University), <bold>C. Klaiman</bold> (Associate Professor, Pediatrics, Emory University), <bold>D.N. Klein</bold> (Professor, Clinical Psychology, Stony Brook University), <bold>M. McCloskey</bold> (Professor, Cognitive Science and Psychology, Johns Hopkins University), <bold>A.C. Miers</bold> (Associate Professor, Developmental and Educational Psychology, Leiden University), <bold>K.G.M. Moons</bold> (Professor, Clinical Epidemiology, Utrecht University), <bold>L. Mosqueda</bold> (Professor, Medicine, University of Southern California), <bold>H.A. Schwartz</bold> (Associate Professor, Computer Science, Stony Brook University), <bold>M. Stein</bold> (Professor, Psychiatry and Behavioral Sciences, University of Washington), <bold>J.G. Tillman</bold> (PhD, Clinical Psychology, Yale School of Medicine), <bold>Y.P. Wang</bold> (MD, PhD, Medicine, University of Sao Paulo Medical School), and <bold>J. Yonashiro-Cho</bold> (PhD, Medicine, University of Southern California).</p><p id="P41">Participants in Delphi Round 2.</p><p id="P42"><bold>I. Augenstein</bold> (Professor, Computer Science, University of Copenhagen), <bold>S. Aydin</bold> (PhD, Developmental and Educational Psychology, Leiden University), <bold>J.R. Boehnke</bold> (PhD, School of Health Sciences, University of Dundee), <bold>G.A. Carlson</bold> (Professor, Psychiatry, Stony Brook University), <bold>K.A.S. Davis</bold> (Researcher, Psychiatry Psychology and Neuroscience, King's College London), <bold>E.I. Fried</bold> (Associate Professor, Clinical Psychology, Leiden University), <bold>P. Gustafsson</bold> (Associate Professor, Child and Adolescent Psychiatry, Lund University), <bold>R. Handels</bold> (Assistant Professor, Psychiatry and Neuropsychology, Maastricht University), <bold>K. Jenniskens</bold> (Assistant Professor, Clinical Epidemiology, Utrecht University), <bold>C. Klaiman</bold> (Associate Professor, Pediatrics, Emory University), <bold>D.N. Klein</bold> (Professor, Clinical Psychology, Stony Brook University), <bold>M. McCloskey</bold> (Professor, Cognitive Science and Psychology, Johns Hopkins University), <bold>A.C. Miers</bold> (Associate Professor, Developmental and Educational Psychology, Leiden University), <bold>K.G.M. Moons</bold> (Professor, Clinical Epidemiology, Utrecht University), <bold>L. Mosqueda</bold> (Professor, Medicine, University of Southern California), <bold>Y. P. Wang</bold> (MD, PhD, Medicine, University of Sao Paulo Medical School), and <bold>J. Yonashiro-Cho</bold> (PhD, Medicine, University of Southern California).</p><p id="P43">Test-users.</p><p id="P44"><bold>T. Ivarsson</bold> (Associate Professor, Neuroscience and Physiology, University of Gothenburg) and <bold>P.J. Snelling</bold> (PhD, Medicine, Gold Coast University Hospital and Griffith University).</p><sec id="S26"><title>Funding sources</title><p id="P45">V.C. Eijsbroek, K. Kjell, and O. Kjell received funding from FORTE (2022&#x02013;01022) and H.A. Schwartz from the National Institutes of Health (Grant R01 AA028032&#x02013;01).</p></sec></ack><fn-group><fn id="FN1"><p id="P46">Ethics approval</p><p id="P47">Swedish law (2003:460) and the Swedish Ethical Review Authority state that only research that includes i) collecting personal information, and/or ii) that involves &#x0201c;obvious&#x0201d; (uppenbar) risk for physical or psychological harm, or iii) involves manipulating or deceiving individuals, should undergo an external ethical review. Considering that the current research involves asking participants to rate and comment on the reporting recommendations, this research does not fall within these criteria. The participants provided their informed consent and their individual open-ended comments and closed-ended ratings in the open material are anonymised. The closed-ended ratings per reporting standard in the <xref rid="SD1" ref-type="supplementary-material">Supplementary Material</xref> are presented on group level. The study is deemed exempt from requiring ethical approval according to Swedish Law (see <xref rid="S16" ref-type="sec">&#x000a7;3</xref>&#x02013;<xref rid="S18" ref-type="sec">4</xref> of the Act [2003:460] on ethical review of research involving humans in Sweden). Hence, the research should not be reviewed by the Swedish Ethical Review Authority. More information can be found at the Swedish Ethical Review Authority (<ext-link xlink:href="https://etikprovningsmyndigheten.se/" ext-link-type="uri">https://etikprovningsmyndigheten.se/</ext-link>).</p></fn><fn id="FN2"><p id="P48">Open Science</p><p id="P49">Open data (Delphi rounds 1 and 2), code (analyses), and material (surveys) can be found on the Open Science Framework: <ext-link xlink:href="https://osf.io/fkv4b/" ext-link-type="uri">https://osf.io/fkv4b/</ext-link>.</p></fn><fn id="FN3"><p id="P50">CRediT authorship contribution statement</p><p id="P51"><bold>Veerle C. Eijsbroek:</bold> Writing &#x02013; review &#x00026; editing, Writing &#x02013; original draft, Visualization, Resources, Project administration, Methodology, Investigation, Formal analysis, Data curation, Conceptualization. <bold>Katarina Kjell:</bold> Writing &#x02013; review &#x00026; editing, Writing &#x02013; original draft, Resources, Project administration, Methodology, Investigation, Funding acquisition, Conceptualization. <bold>H. Andrew Schwartz:</bold> Writing &#x02013; review &#x00026; editing, Resources, Methodology. <bold>Jan R. Boehnke:</bold> Writing &#x02013; review &#x00026; editing, Resources, Methodology. <bold>Eiko I. Fried:</bold> Writing &#x02013; review &#x00026; editing, Resources, Methodology. <bold>Daniel N. Klein:</bold> Writing &#x02013; review &#x00026; editing, Resources, Methodology. <bold>Peik Gustafsson:</bold> Writing &#x02013; review &#x00026; editing, Resources, Methodology. <bold>Isabelle Augenstein:</bold> Writing &#x02013; review &#x00026; editing, Resources, Methodology. <bold>Patrick M.M. Bossuyt:</bold> Writing &#x02013; review &#x00026; editing, Resources, Methodology. <bold>Oscar N.E. Kjell:</bold> Writing &#x02013; review &#x00026; editing, Writing &#x02013; original draft, Supervision, Resources, Project administration, Methodology, Investigation, Funding acquisition, Formal analysis, Conceptualization.</p></fn><fn fn-type="COI-statement" id="FN4"><p id="P52">Declaration of competing interest</p><p id="P53">O. Kjell and K. Kjell have co-founded and hold shares in a start-up using computational language assessments to diagnose mental health problems based on best-estimate assessments and J.R. Boehnke is as editor part of the International Society for Quality of Life Research.</p></fn><fn id="FN5"><p id="P54">Public Health Significance</p><p id="P55">Accurate assessments of symptoms and illnesses are essential for health research and clinical practice but face many challenges. We have developed the LEADING guideline, including reporting standards that assist in planning, reporting, and evaluating methods involving experts reviewing several sources of (longitudinal) information to achieve <italic toggle="yes">best-estimate assessments</italic> in psychology, psychiatry, and medicine.</p></fn><fn id="FN6"><p id="P56">Patient and public involvement</p><p id="P57">Prior to the Delphi procedure and test procedures, the reporting standards with inclusion rationales were discussed in an online workshop with a patient organization for depression (the chairman and vice chairman from Libra Balans Sk&#x000e5;ne), followed by receiving feedback from the steering group members to receive a wide range of perspectives early in the process.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>[1]</label><mixed-citation publication-type="journal"><name><surname>Hirschtritt</surname><given-names>ME</given-names></name>, <name><surname>Insel</surname><given-names>TR</given-names></name>. <article-title>Digital technologies in psychiatry: present and future</article-title>. <source>Focus Am Psychiatr Publ</source>
<year>2018</year>;<volume>16</volume>(<issue>3</issue>):<fpage>251</fpage>&#x02013;<lpage>8</lpage>. <month>Jul</month>.<pub-id pub-id-type="pmid">31975919</pub-id>
</mixed-citation></ref><ref id="R2"><label>[2]</label><mixed-citation publication-type="journal"><name><surname>Venkatasubramanian</surname><given-names>G</given-names></name>, <name><surname>Keshavan</surname><given-names>MS</given-names></name>. <article-title>Biomarkers in psychiatry - a critique</article-title>. <source>Ann Neurosci</source>
<year>2016</year>;<volume>23</volume>(<issue>1</issue>):<fpage>3</fpage>&#x02013;<lpage>5</lpage>. <month>Mar</month>.<pub-id pub-id-type="pmid">27536015</pub-id>
</mixed-citation></ref><ref id="R3"><label>[3]</label><mixed-citation publication-type="journal"><name><surname>Cronbach</surname><given-names>LJ</given-names></name>, <name><surname>Meehl</surname><given-names>PE</given-names></name>. <article-title>Construct validity in psychological tests</article-title>. <source>Psychol Bull</source>
<year>1955</year>;<volume>52</volume>(<issue>4</issue>):<fpage>281</fpage>&#x02013;<lpage>302</lpage>. <month>Jul</month>.<pub-id pub-id-type="pmid">13245896</pub-id>
</mixed-citation></ref><ref id="R4"><label>[4]</label><mixed-citation publication-type="journal"><name><surname>Lilienfeld Scott</surname><given-names>O</given-names></name>, <name><surname>Katheryn</surname><given-names>Sauvigne</given-names></name>, <name><surname>Jay</surname><given-names>Lynn Steven</given-names></name>, <name><surname>Latzman Robert</surname><given-names>D</given-names></name>, <name><surname>Robin</surname><given-names>Cautin</given-names></name>, <name><surname>Waldman Irwin</surname><given-names>D</given-names></name>. <article-title>Fifty psychological and psychiatric terms to avoid: a list of inaccurate, misleading, misused, ambiguous, and logically confused words and phrases</article-title>. <source>Front Psychol</source>
<year>2015</year>;<volume>6</volume>. <month>Aug</month>
<day>1</day>.</mixed-citation></ref><ref id="R5"><label>[5]</label><mixed-citation publication-type="journal"><name><surname>Spitzer</surname><given-names>RL</given-names></name>. <article-title>Psychiatric diagnosis: are clinicians still necessary?</article-title>
<source>Compr Psychiatry</source>
<year>1983</year>;<volume>24</volume>(<issue>5</issue>):<fpage>399</fpage>&#x02013;<lpage>411</lpage>. <month>Sep</month>.<pub-id pub-id-type="pmid">6354575</pub-id>
</mixed-citation></ref><ref id="R6"><label>[6]</label><mixed-citation publication-type="journal"><name><surname>Leckman</surname><given-names>JF</given-names></name>, <name><surname>Sholomskas</surname><given-names>D</given-names></name>, <name><surname>Thompson</surname><given-names>WD</given-names></name>, <name><surname>Belanger</surname><given-names>A</given-names></name>, <name><surname>Weissman</surname><given-names>MM</given-names></name>. <article-title>Best estimate of lifetime psychiatric diagnosis: a methodological study</article-title>. <source>Arch Gen Psychiatry</source>
<year>1982</year>;<volume>39</volume>(<issue>8</issue>):<fpage>879</fpage>&#x02013;<lpage>83</lpage>. <month>Aug</month>.<pub-id pub-id-type="pmid">7103676</pub-id>
</mixed-citation></ref><ref id="R7"><label>[7]</label><mixed-citation publication-type="journal"><name><surname>Bertens</surname><given-names>LCM</given-names></name>, <name><surname>Broekhuizen</surname><given-names>BDL</given-names></name>, <name><surname>Naaktgeboren</surname><given-names>CA</given-names></name>, <name><surname>Rutten</surname><given-names>FH</given-names></name>, <name><surname>Hoes</surname><given-names>AW</given-names></name>, <name><surname>van Mourik</surname><given-names>Y</given-names></name>, <etal/>
<article-title>Use of expert panels to define the reference standard in diagnostic research: a systematic review of published methods and reporting</article-title>. <source>PLoS Med</source>
<year>2013</year>; <volume>10</volume>(<issue>10</issue>). <month>Oct</month>
<day>15</day>. (e1001531).</mixed-citation></ref><ref id="R8"><label>[8]</label><mixed-citation publication-type="journal"><name><surname>Hunsley</surname><given-names>J</given-names></name>, <name><surname>Mash</surname><given-names>EJ</given-names></name>. <article-title>Evidence-based assessment</article-title>. <source>Annu Rev Clin Psychol</source>
<year>2007</year>;<volume>3</volume>: <fpage>29</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="pmid">17716047</pub-id>
</mixed-citation></ref><ref id="R9"><label>[9]</label><mixed-citation publication-type="journal"><name><surname>Niculescu</surname><given-names>AB</given-names></name>, <name><surname>Le-Niculescu</surname><given-names>H</given-names></name>. <article-title>Precision medicine in psychiatry: biomarkers to the forefront</article-title>. <source>Neuropsychopharmacol Intersect Brain Behav Ther</source>
<year>2022</year>;<volume>47</volume>(<issue>1</issue>):<fpage>422</fpage>&#x02013;<lpage>3</lpage>. <month>Jan</month>
<day>1</day>.</mixed-citation></ref><ref id="R10"><label>[10]</label><mixed-citation publication-type="journal"><collab>IMAGEN Consortium</collab>, <name><surname>Quinlan</surname><given-names>EB</given-names></name>, <name><surname>Banaschewski</surname><given-names>T</given-names></name>, <name><surname>Barker</surname><given-names>GJ</given-names></name>, <name><surname>Bokde</surname><given-names>ALW</given-names></name>, <name><surname>Bromberg</surname><given-names>U</given-names></name>, <etal/>
<article-title>Identifying biological markers for improved precision medicine in psychiatry</article-title>. <source>Mol Psychiatry</source>
<year>2020</year>;<volume>25</volume>(<issue>2</issue>):<fpage>243</fpage>&#x02013;<lpage>53</lpage>. <month>Feb</month>.<pub-id pub-id-type="pmid">31676814</pub-id>
</mixed-citation></ref><ref id="R11"><label>[11]</label><mixed-citation publication-type="journal"><name><surname>Maria Salud</surname><given-names>Garc&#x000ed;a-Guti&#x000e9;rrez</given-names></name>, <name><surname>Francisco</surname><given-names>Navarrete</given-names></name>, <name><surname>Francisco</surname><given-names>Sala</given-names></name>, <name><surname>Ani</surname><given-names>Gasparyan</given-names></name>, <name><surname>Amaya</surname><given-names>Austrich-Olivares</given-names></name>, <name><surname>Jorge</surname><given-names>Manzanares</given-names></name>. <article-title>Biomarkers in Psychiatry: concept, definition, types and relevance to the clinical reality</article-title>. <source>Front Psych</source>
<year>2020</year>;<volume>11</volume>. <month>May</month>
<day>1</day>.</mixed-citation></ref><ref id="R12"><label>[12]</label><mixed-citation publication-type="journal"><name><surname>Giovanni</surname><given-names>Briganti</given-names></name>, <name><surname>Olivier</surname><given-names>Le Moine</given-names></name>. <article-title>Artificial intelligence in medicine: today and tomorrow</article-title>. <source>Front Med</source>
<year>2020</year>:<fpage>7</fpage>. <month>Feb</month>
<day>1</day>.</mixed-citation></ref><ref id="R13"><label>[13]</label><mixed-citation publication-type="journal"><name><surname>Rajpurkar</surname><given-names>P</given-names></name>, <name><surname>Chen</surname><given-names>E</given-names></name>, <name><surname>Banerjee</surname><given-names>O</given-names></name>, <name><surname>Topol</surname><given-names>EJ</given-names></name>. <article-title>AI in health and medicine</article-title>. <source>Nat Med</source>
<year>2022</year>;<volume>28</volume>(<issue>1</issue>):<fpage>31</fpage>&#x02013;<lpage>8</lpage>. <month>Jan</month>.<pub-id pub-id-type="pmid">35058619</pub-id>
</mixed-citation></ref><ref id="R14"><label>[14]</label><mixed-citation publication-type="journal"><name><surname>Wiemken</surname><given-names>TL</given-names></name>, <name><surname>Kelley</surname><given-names>RR</given-names></name>. <article-title>Machine learning in epidemiology and health outcomes research</article-title>. <source>Annu Rev Public Health</source>
<year>2020</year>;<volume>41</volume>(<issue>1</issue>):<fpage>21</fpage>&#x02013;<lpage>36</lpage>.<pub-id pub-id-type="pmid">31577910</pub-id>
</mixed-citation></ref><ref id="R15"><label>[15]</label><mixed-citation publication-type="journal"><name><surname>Handels</surname><given-names>RLH</given-names></name>, <name><surname>Wolfs</surname><given-names>CAG</given-names></name>, <name><surname>Aalten</surname><given-names>P</given-names></name>, <name><surname>Bossuyt</surname><given-names>PMM</given-names></name>, <name><surname>Joore</surname><given-names>MA</given-names></name>, <name><surname>Leentjens</surname><given-names>AFG</given-names></name>, <etal/>
<article-title>Optimizing the use of expert panel reference diagnoses in diagnostic studies of multidimensional syndromes</article-title>. <source>BMC Neurol</source>
<year>2014</year>;<volume>14</volume>:<fpage>190</fpage>. <month>Oct</month>
<day>4</day>.<pub-id pub-id-type="pmid">25280531</pub-id>
</mixed-citation></ref><ref id="R16"><label>[16]</label><mixed-citation publication-type="journal"><name><surname>Reitsma</surname><given-names>JB</given-names></name>, <name><surname>Rutjes</surname><given-names>AWS</given-names></name>, <name><surname>Khan</surname><given-names>KS</given-names></name>, <name><surname>Coomarasamy</surname><given-names>A</given-names></name>, <name><surname>Bossuyt</surname><given-names>PM</given-names></name>. <article-title>A review of solutions for diagnostic accuracy studies with an imperfect or missing reference standard</article-title>. <source>J Clin Epidemiol</source>
<year>2009</year>;<volume>62</volume>(<issue>8</issue>):<fpage>797</fpage>&#x02013;<lpage>806</lpage>. <month>Jan</month>
<day>1</day>.<pub-id pub-id-type="pmid">19447581</pub-id>
</mixed-citation></ref><ref id="R17"><label>[17]</label><mixed-citation publication-type="journal"><name><surname>Klein</surname><given-names>DN</given-names></name>, <name><surname>Ouimette</surname><given-names>PC</given-names></name>, <name><surname>Kelly</surname><given-names>HS</given-names></name>, <name><surname>Ferro</surname><given-names>T</given-names></name>, <name><surname>Riso</surname><given-names>LP</given-names></name>. <article-title>Test-retest reliability of team consensus best-estimate diagnoses of axis I and II disorders in a family study</article-title>. <source>Am J Psychiatry</source>
<year>1994</year>;<volume>151</volume>(<issue>7</issue>):<fpage>1043</fpage>&#x02013;<lpage>7</lpage>. <month>Jul</month>.<pub-id pub-id-type="pmid">8010362</pub-id>
</mixed-citation></ref><ref id="R18"><label>[18]</label><mixed-citation publication-type="journal"><name><surname>Robins</surname><given-names>LN</given-names></name>, <name><surname>Helzer</surname><given-names>JE</given-names></name>, <name><surname>Croughan</surname><given-names>J</given-names></name>, <name><surname>Ratcliff</surname><given-names>KS</given-names></name>. <article-title>National Institute of Mental Health diagnostic interview schedule. Its history, characteristics, and validity</article-title>. <source>Arch Gen Psychiatry</source>
<year>1981</year>;<volume>38</volume>(<issue>4</issue>):<fpage>381</fpage>&#x02013;<lpage>9</lpage>. <month>Apr</month>.<pub-id pub-id-type="pmid">6260053</pub-id>
</mixed-citation></ref><ref id="R19"><label>[19]</label><mixed-citation publication-type="journal"><name><surname>Gagnon</surname><given-names>R</given-names></name>, <name><surname>Charlin</surname><given-names>B</given-names></name>, <name><surname>Coletti</surname><given-names>M</given-names></name>, <name><surname>Sauv&#x000e9;</surname><given-names>E</given-names></name>, <name><surname>van der Vleuten</surname><given-names>C</given-names></name>. <article-title>Assessment in the context of uncertainty: how many members are needed on the panel of reference of a script concordance test?</article-title>
<source>Med Educ</source>
<year>2005</year>;<volume>39</volume>(<issue>3</issue>):<fpage>284</fpage>&#x02013;<lpage>91</lpage>. <month>Mar</month>.<pub-id pub-id-type="pmid">15733164</pub-id>
</mixed-citation></ref><ref id="R20"><label>[20]</label><mixed-citation publication-type="journal"><name><surname>Knottnerus</surname><given-names>JA</given-names></name>, <name><surname>Muris</surname><given-names>JW</given-names></name>. <article-title>Assessment of the accuracy of diagnostic tests: the cross-sectional study</article-title>. <source>J Clin Epidemiol</source>
<year>2003</year>;<volume>56</volume>(<issue>11</issue>):<fpage>1118</fpage>&#x02013;<lpage>28</lpage>. <month>Nov</month>
<day>1</day>.<pub-id pub-id-type="pmid">14615003</pub-id>
</mixed-citation></ref><ref id="R21"><label>[21]</label><mixed-citation publication-type="journal"><name><surname>Hogberg</surname><given-names>C</given-names></name>, <name><surname>Billstedt</surname><given-names>E</given-names></name>, <name><surname>Bjorck</surname><given-names>C</given-names></name>, <name><surname>Bjorck</surname><given-names>P</given-names></name>, <name><surname>Ehlers</surname><given-names>S</given-names></name>, <name><surname>Gustle</surname><given-names>L</given-names></name>, <etal/>
<article-title>Diagnostic validity of the MINI-KID disorder classifications in specialized child and adolescent psychiatric outpatient clinics in Sweden</article-title>. <source>BMC Psychiatry</source>
<year>2019</year>;<volume>19</volume>(<issue>1</issue>):<fpage>142</fpage>. <month>Jan</month>
<day>1</day>.<pub-id pub-id-type="pmid">31072319</pub-id>
</mixed-citation></ref><ref id="R22"><label>[22]</label><mixed-citation publication-type="journal"><name><surname>Anglin</surname><given-names>DM</given-names></name>, <name><surname>Malaspina</surname><given-names>D</given-names></name>. <article-title>Ethnicity effects on clinical diagnoses compared to best-estimate research diagnoses in patients with psychosis: a retrospective medical chart review</article-title>. <source>J Clin Psychiatry</source>
<year>2008</year>;<volume>69</volume>(<issue>6</issue>):<fpage>941</fpage>&#x02013;<lpage>5</lpage>. <month>Jun</month>.<pub-id pub-id-type="pmid">18494534</pub-id>
</mixed-citation></ref><ref id="R23"><label>[23]</label><mixed-citation publication-type="journal"><name><surname>Bech</surname><given-names>P</given-names></name>, <name><surname>Timmerby</surname><given-names>N</given-names></name>, <name><surname>Martiny</surname><given-names>K</given-names></name>, <name><surname>Lunde</surname><given-names>M</given-names></name>, <name><surname>Soendergaard</surname><given-names>S</given-names></name>. <article-title>Psychometric evaluation of the major depression inventory (MDI) as depression severity scale using the LEAD (longitudinal expert assessment of all data) as index of validity</article-title>. <source>BMC Psychiatry</source>
<year>2015</year>;<volume>15</volume>:<fpage>190</fpage>. <month>Aug</month>
<day>5</day>.<pub-id pub-id-type="pmid">26242577</pub-id>
</mixed-citation></ref><ref id="R24"><label>[24]</label><mixed-citation publication-type="journal"><name><surname>Ruitian</surname><given-names>Gao</given-names></name>, <name><surname>Shuai</surname><given-names>Zhao</given-names></name>, <name><surname>Kedeerya</surname><given-names>Aishanjiang</given-names></name>, <name><surname>Hao</surname><given-names>Cai</given-names></name>, <name><surname>Ting</surname><given-names>Wei</given-names></name>, <name><surname>Yichi</surname><given-names>Zhang</given-names></name>, <etal/>
<article-title>Deep learning for differential diagnosis of malignant hepatic tumors based on multi-phase contrast-enhanced CT and clinical data</article-title>. <source>J Hematol OncolJ Hematol Oncol</source>
<year>2021</year>;<volume>14</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>7</lpage>. <month>Sep</month>
<day>1</day>.<pub-id pub-id-type="pmid">33402199</pub-id>
</mixed-citation></ref><ref id="R25"><label>[25]</label><mixed-citation publication-type="journal"><name><surname>B&#x000f6;sner</surname><given-names>S</given-names></name>, <name><surname>Haasenritter</surname><given-names>J</given-names></name>, <name><surname>Becker</surname><given-names>A</given-names></name>, <name><surname>Heinzel-Gutenbrunner</surname><given-names>M</given-names></name>, <name><surname>Hani</surname><given-names>MA</given-names></name>, <name><surname>Keller</surname><given-names>H</given-names></name>, <etal/>
<article-title>Ruling out coronary artery disease in primary care: development and validation of a simple prediction rule</article-title>. <source>CMAJ. Can Med Assoc J</source>
<year>2010</year>;<volume>182</volume>(<issue>12</issue>): <fpage>1295</fpage>&#x02013;<lpage>300</lpage>. <month>Sep</month>
<day>7</day>.<pub-id pub-id-type="pmid">20603345</pub-id>
</mixed-citation></ref><ref id="R26"><label>[26]</label><mixed-citation publication-type="journal"><name><surname>Cowan</surname><given-names>KJ</given-names></name>, <name><surname>Tandias</surname><given-names>A</given-names></name>, <name><surname>Arndt</surname><given-names>B</given-names></name>, <name><surname>Hanrahan</surname><given-names>L</given-names></name>, <name><surname>Mundt</surname><given-names>M</given-names></name>, <name><surname>Guilbert</surname><given-names>TW</given-names></name>. <article-title>Defining asthma: validating automated electronic health record algorithm with expert panel diagnosis</article-title>. <source>Am J Respir Crit Care Med</source>
<year>2014</year>:<fpage>189</fpage>. <month>Jan</month>
<day>1</day>.</mixed-citation></ref><ref id="R27"><label>[27]</label><mixed-citation publication-type="journal"><name><surname>Black</surname><given-names>DW</given-names></name>, <name><surname>Coryell</surname><given-names>WH</given-names></name>, <name><surname>Crowe</surname><given-names>RR</given-names></name>, <name><surname>McCormick</surname><given-names>B</given-names></name>, <name><surname>Shaw</surname><given-names>MC</given-names></name>, <name><surname>Allen</surname><given-names>J</given-names></name>. <article-title>A direct, controlled, blind family study of DSM-IV pathological gambling</article-title>. <source>J Clin Psychiatry</source>
<year>2014</year>;<volume>75</volume>(<issue>3</issue>):<fpage>215</fpage>&#x02013;<lpage>21</lpage>. <month>Mar</month>.<pub-id pub-id-type="pmid">24500179</pub-id>
</mixed-citation></ref><ref id="R28"><label>[28]</label><mixed-citation publication-type="journal"><name><surname>Reas</surname><given-names>DL</given-names></name>, <name><surname>R&#x000f8;</surname><given-names>O</given-names></name>, <name><surname>Karterud</surname><given-names>S</given-names></name>, <name><surname>Hummelen</surname><given-names>B</given-names></name>, <name><surname>Pedersen</surname><given-names>G</given-names></name>. <article-title>Eating disorders in a large clinical sample of men and women with personality disorders</article-title>. <source>Int J Eat Disord</source>
<year>2013</year>;<volume>46</volume>(<issue>8</issue>):<fpage>801</fpage>&#x02013;<lpage>9</lpage>. <month>Dec</month>
<day>1</day>.<pub-id pub-id-type="pmid">23983043</pub-id>
</mixed-citation></ref><ref id="R29"><label>[29]</label><mixed-citation publication-type="journal"><name><surname>Hall</surname><given-names>WB</given-names></name>, <name><surname>Truitt</surname><given-names>SG</given-names></name>, <name><surname>Scheunemann</surname><given-names>LP</given-names></name>, <name><surname>Shah</surname><given-names>SA</given-names></name>, <name><surname>Rivera</surname><given-names>MP</given-names></name>, <name><surname>Parker</surname><given-names>LA</given-names></name>, <etal/>
<article-title>The prevalence of clinically relevant incidental findings on chest computed tomographic angiograms ordered to diagnose pulmonary embolism</article-title>. <source>Arch Intern Med</source>
<year>2009</year>;<volume>169</volume>(<issue>21</issue>):<fpage>1961</fpage>&#x02013;<lpage>5</lpage>. <month>Nov</month>
<day>23</day>.<pub-id pub-id-type="pmid">19933956</pub-id>
</mixed-citation></ref><ref id="R30"><label>[30]</label><mixed-citation publication-type="journal"><name><surname>Brian</surname><given-names>J</given-names></name>, <name><surname>Roberts</surname><given-names>W</given-names></name>, <name><surname>Szatmari</surname><given-names>P</given-names></name>, <name><surname>Bryson</surname><given-names>SE</given-names></name>, <name><surname>Smith</surname><given-names>IM</given-names></name>, <name><surname>Roncadin</surname><given-names>C</given-names></name>, <etal/>
<article-title>Stability and change in autism spectrum disorder diagnosis from age 3 to middle childhood in a high-risk sibling cohort</article-title>. <source>Autism</source>
<year>2016</year>;<volume>20</volume>(<issue>7</issue>):<fpage>888</fpage>&#x02013;<lpage>92</lpage>. <month>Oct</month>
<day>1</day>.<pub-id pub-id-type="pmid">26685198</pub-id>
</mixed-citation></ref><ref id="R31"><label>[31]</label><mixed-citation publication-type="journal"><name><surname>Duffy</surname><given-names>A</given-names></name>, <name><surname>Grof</surname><given-names>P</given-names></name>, <name><surname>Goodday</surname><given-names>S</given-names></name>, <name><surname>Keown-Stoneman</surname><given-names>C</given-names></name>. <article-title>The emergent course of bipolar disorder: observations over two decades from the Canadian high-risk offspring cohort</article-title>. <source>Am J Psychiatry</source>
<year>2019</year>;<volume>176</volume>(<issue>9</issue>):<fpage>720</fpage>&#x02013;<lpage>9</lpage>. <month>Jan</month>
<day>1</day>.<pub-id pub-id-type="pmid">30525908</pub-id>
</mixed-citation></ref><ref id="R32"><label>[32]</label><mixed-citation publication-type="journal"><name><surname>Elias</surname><given-names>R</given-names></name>, <name><surname>Lord</surname><given-names>C</given-names></name>. <article-title>Diagnostic stability in individuals with autism spectrum disorder: insights from a longitudinal follow-up study</article-title>. <source>J Child Psychol Psychiatry</source>
<year>2022</year>;<volume>63</volume> (<issue>9</issue>):<fpage>973</fpage>&#x02013;<lpage>83</lpage>. <month>Sep</month>
<day>1</day>.<pub-id pub-id-type="pmid">34890046</pub-id>
</mixed-citation></ref><ref id="R33"><label>[33]</label><mixed-citation publication-type="journal"><name><surname>Pedersen</surname><given-names>G</given-names></name>, <name><surname>Karterud</surname><given-names>S</given-names></name>, <name><surname>Wilberg</surname><given-names>T</given-names></name>, <name><surname>Hummelen</surname><given-names>B</given-names></name>. <article-title>The impact of extended longitudinal observation on the assessment of personality disorders</article-title>. <source>Personal Ment Health</source>
<year>2013</year>;<volume>7</volume>(<issue>4</issue>):<fpage>277</fpage>&#x02013;<lpage>87</lpage>. <month>Nov</month>
<day>1</day>.<pub-id pub-id-type="pmid">24343977</pub-id>
</mixed-citation></ref><ref id="R34"><label>[34]</label><mixed-citation publication-type="journal"><name><surname>Yonashiro-Cho</surname><given-names>JMF</given-names></name>, <name><surname>Gassoumis</surname><given-names>ZD</given-names></name>, <name><surname>Homeier</surname><given-names>DC</given-names></name>, <name><surname>Wilber</surname><given-names>KH</given-names></name>. <article-title>Improving forensics: characterizing injuries among community-dwelling physically abused older adults</article-title>. <source>J Am Geriatr Soc</source>
<year>2021</year>;<volume>69</volume>(<issue>8</issue>):<fpage>2252</fpage>&#x02013;<lpage>61</lpage>. <month>Aug</month>
<day>1</day>.<pub-id pub-id-type="pmid">33945150</pub-id>
</mixed-citation></ref><ref id="R35"><label>[35]</label><mixed-citation publication-type="journal"><name><surname>Oudejans</surname><given-names>I</given-names></name>, <name><surname>Mosterd</surname><given-names>A</given-names></name>, <name><surname>Bloemen</surname><given-names>JA</given-names></name>, <name><surname>Valk</surname><given-names>MJ</given-names></name>, <name><surname>van Velzen</surname><given-names>E</given-names></name>, <name><surname>Wielders</surname><given-names>JP</given-names></name>, <etal/>
<article-title>Clinical evaluation of geriatric outpatients with suspected heart failure: value of symptoms, signs, and additional tests</article-title>. <source>Eur J Heart Fail</source>
<year>2011</year>;<volume>13</volume>(<issue>5</issue>):<fpage>518</fpage>&#x02013;<lpage>27</lpage>.<pub-id pub-id-type="pmid">21422000</pub-id>
</mixed-citation></ref><ref id="R36"><label>[36]</label><mixed-citation publication-type="journal"><name><surname>Mooney</surname><given-names>MA</given-names></name>, <name><surname>Wilmot</surname><given-names>B</given-names></name>, <name><surname>Bhatt</surname><given-names>P</given-names></name>, <name><surname>Nigg</surname><given-names>JT</given-names></name>, <name><surname>Hermosillo</surname><given-names>RJM</given-names></name>, <name><surname>Fair</surname><given-names>DA</given-names></name>, <etal/>
<article-title>Smaller total brain volume but not subcortical structure volume related to common genetic risk for ADHD</article-title>. <source>Psychol Med</source>
<year>2021</year>;<volume>51</volume>(<issue>8</issue>):<fpage>1279</fpage>&#x02013;<lpage>88</lpage>. <month>Jun</month>
<day>1</day>.<pub-id pub-id-type="pmid">31973781</pub-id>
</mixed-citation></ref><ref id="R37"><label>[37]</label><mixed-citation publication-type="journal"><name><surname>Lamers</surname><given-names>F</given-names></name>, <name><surname>Cui</surname><given-names>L</given-names></name>, <name><surname>Hickie</surname><given-names>IB</given-names></name>, <name><surname>Roca</surname><given-names>C</given-names></name>, <name><surname>Machado-Vieira</surname><given-names>R</given-names></name>, <name><surname>Zarate</surname><given-names>CA</given-names><suffix>Jr</suffix></name>, <etal/>
<article-title>Familial aggregation and heritability of the melancholic and atypical subtypes of depression</article-title>. <source>J Affect Disord</source>
<year>2016</year>;<volume>204</volume>:<fpage>241</fpage>&#x02013;<lpage>6</lpage>. <month>Nov</month>
<day>1</day>.<pub-id pub-id-type="pmid">27450632</pub-id>
</mixed-citation></ref><ref id="R38"><label>[38]</label><mixed-citation publication-type="journal"><name><surname>Merikangas</surname><given-names>KR</given-names></name>, <name><surname>Cui</surname><given-names>L</given-names></name>, <name><surname>Heaton</surname><given-names>L</given-names></name>, <name><surname>Nakamura</surname><given-names>E</given-names></name>, <name><surname>Roca</surname><given-names>C</given-names></name>, <name><surname>Ding</surname><given-names>J</given-names></name>, <etal/>
<article-title>Independence of familial transmission of mania and depression: results of the NIMH family study of affective spectrum disorders</article-title>. <source>Mol Psychiatry</source>
<year>2014</year>;<volume>19</volume>(<issue>2</issue>):<fpage>214</fpage>&#x02013;<lpage>9</lpage>. <month>Feb</month>
<day>1</day>.<pub-id pub-id-type="pmid">24126930</pub-id>
</mixed-citation></ref><ref id="R39"><label>[39]</label><mixed-citation publication-type="journal"><name><surname>Mataix-Cols</surname><given-names>D</given-names></name>, <name><surname>Billotti</surname><given-names>D</given-names></name>, <name><surname>Fern&#x000e1;ndez De La Cruz</surname><given-names>L</given-names></name>, <name><surname>Nordsletten</surname><given-names>AE</given-names></name>. <article-title>The London field trial for hoarding disorder</article-title>. <source>Psychol Med</source>
<year>2013</year>;<volume>43</volume>(<issue>4</issue>):<fpage>837</fpage>&#x02013;<lpage>47</lpage>. <month>Apr</month>.<pub-id pub-id-type="pmid">22883395</pub-id>
</mixed-citation></ref><ref id="R40"><label>[40]</label><mixed-citation publication-type="journal"><name><surname>Dereboy</surname><given-names>F</given-names></name>, <name><surname>Dereboy</surname><given-names>&#x000c7;</given-names></name>, <name><surname>Eskin</surname><given-names>M</given-names></name>. <article-title>Validation of the DSM&#x02013;5 alternative model personality disorder diagnoses in Turkey, part 1: LEAD validity and reliability of the personality functioning ratings</article-title>. <source>J Pers Assess</source>
<year>2018</year>;<volume>100</volume>(<issue>6</issue>):<fpage>603</fpage>&#x02013;<lpage>11</lpage>. <month>Nov</month>.<pub-id pub-id-type="pmid">29465265</pub-id>
</mixed-citation></ref><ref id="R41"><label>[41]</label><mixed-citation publication-type="journal"><name><surname>Sung</surname><given-names>M</given-names></name>, <name><surname>Goh</surname><given-names>TJ</given-names></name>, <name><surname>Tan</surname><given-names>BLJ</given-names></name>, <name><surname>Chan</surname><given-names>JS</given-names></name>, <name><surname>Liew</surname><given-names>HSA</given-names></name>. <article-title>Comparison of DSM-IV-TR and DSM-5 criteria in diagnosing autism spectrum disorders in Singapore</article-title>. <source>J Autism Dev Disord</source>
<year>2018</year>;<volume>48</volume>(<issue>10</issue>):<fpage>3273</fpage>&#x02013;<lpage>81</lpage>. <month>Oct</month>.<pub-id pub-id-type="pmid">29705921</pub-id>
</mixed-citation></ref><ref id="R42"><label>[42]</label><mixed-citation publication-type="journal"><name><surname>Takeshi</surname><given-names>Nishiyama</given-names></name>, <name><surname>Satoshi</surname><given-names>Sumi</given-names></name>, <name><surname>Hiroto</surname><given-names>Watanabe</given-names></name>, <name><surname>Futoshi</surname><given-names>Suzuki</given-names></name>, <name><surname>Yukiko</surname><given-names>Kuru</given-names></name>, <name><surname>Tomoko</surname><given-names>Shiino</given-names></name>, <etal/>
<article-title>The kiddie schedule for affective disorders and schizophrenia present and lifetime version (K-SADS-PL) for DSM-5: a validation for neurodevelopmental disorders in Japanese outpatients</article-title>. <source>Compr Psychiatry</source>
<year>2020</year>:<fpage>96</fpage>. <month>Jan</month>
<day>1</day>.</mixed-citation></ref><ref id="R43"><label>[43]</label><mixed-citation publication-type="journal"><name><surname>Gerdner</surname><given-names>A</given-names></name>, <name><surname>Kestenberg</surname><given-names>J</given-names></name>, <name><surname>Mattias</surname><given-names>E</given-names></name>. <article-title>Validity of the Swedish SCID and ADDIS diagnostic interviews for substance use disorders: sensitivity and specificity compared with a LEAD golden standard</article-title>. <source>Nord J Psychiatry</source>
<year>2015</year>;<volume>69</volume>(<issue>1</issue>):<fpage>48</fpage>&#x02013;<lpage>56</lpage>. <month>Jan</month>
<day>1</day>.<pub-id pub-id-type="pmid">25298163</pub-id>
</mixed-citation></ref><ref id="R44"><label>[44]</label><mixed-citation publication-type="journal"><name><surname>North</surname><given-names>CS</given-names></name>, <name><surname>Simic</surname><given-names>Z</given-names></name>, <name><surname>Burruss</surname><given-names>J</given-names></name>. <article-title>Design, implementation, and assessment of a public comprehensive specialty care program for early psychosis</article-title>. <source>J Psychiatr Pract</source>
<year>2019</year>; <volume>25</volume>(<issue>2</issue>):<fpage>91</fpage>&#x02013;<lpage>102</lpage>. <month>Mar</month>.<pub-id pub-id-type="pmid">30849057</pub-id>
</mixed-citation></ref><ref id="R45"><label>[45]</label><mixed-citation publication-type="journal"><name><surname>Blackmore</surname><given-names>R</given-names></name>, <name><surname>Gray</surname><given-names>KM</given-names></name>, <name><surname>Melvin</surname><given-names>GA</given-names></name>, <name><surname>Newman</surname><given-names>L</given-names></name>, <name><surname>Boyle</surname><given-names>JA</given-names></name>, <name><surname>Gibson-Helm</surname><given-names>M</given-names></name>. <article-title>Identifying post-traumatic stress disorder in women of refugee background at a public antenatal clinic</article-title>. <source>Arch Womens Ment Health</source>
<year>2022</year>;<volume>25</volume>(<issue>1</issue>):<fpage>191</fpage>&#x02013;<lpage>8</lpage>. <month>Feb</month>.<pub-id pub-id-type="pmid">34351511</pub-id>
</mixed-citation></ref><ref id="R46"><label>[46]</label><mixed-citation publication-type="journal"><name><surname>Os&#x000f3;rio</surname><given-names>FL</given-names></name>, <name><surname>Loureiro</surname><given-names>SR</given-names></name>, <name><surname>Hallak</surname><given-names>JEC</given-names></name>, <name><surname>Machado-de-Sousa</surname><given-names>JP</given-names></name>, <name><surname>Ushirohira</surname><given-names>JM</given-names></name>, <name><surname>Baes</surname><given-names>CVW</given-names></name>, <etal/>
<article-title>Clinical validity and intrarater and test-retest reliability of the structured clinical interview for DSM-5 - clinician version (SCID-5-CV)</article-title>. <source>Psychiatry Clin Neurosci</source>
<year>2019</year>;<volume>73</volume>(<issue>12</issue>):<fpage>754</fpage>&#x02013;<lpage>60</lpage>. <month>Dec</month>.<pub-id pub-id-type="pmid">31490607</pub-id>
</mixed-citation></ref><ref id="R47"><label>[47]</label><mixed-citation publication-type="journal"><name><surname>Flake</surname><given-names>JK</given-names></name>, <name><surname>Fried</surname><given-names>EI</given-names></name>. <article-title>Measurement schmeasurement: questionable measurement practices and how to avoid them</article-title>. <source>Adv Methods Pract Psychol Sci</source>
<year>2020</year>;<volume>3</volume>(<issue>4</issue>): <fpage>456</fpage>&#x02013;<lpage>65</lpage>. <month>Dec</month>
<day>1</day>.</mixed-citation></ref><ref id="R48"><label>[48]</label><mixed-citation publication-type="journal"><name><surname>Aguinis</surname><given-names>H</given-names></name>, <name><surname>Ramani</surname><given-names>RS</given-names></name>, <name><surname>Alabduljader</surname><given-names>N</given-names></name>. <article-title>What you see is what you get? Enhancing methodological transparency in management research</article-title>. <source>Acad Manag Ann</source>
<year>2018</year>;<volume>12</volume> (<issue>1</issue>):<fpage>83</fpage>&#x02013;<lpage>110</lpage>. <month>Jan</month>.</mixed-citation></ref><ref id="R49"><label>[49]</label><mixed-citation publication-type="journal"><name><surname>von Elm</surname><given-names>E</given-names></name>, <name><surname>Altman</surname><given-names>DG</given-names></name>, <name><surname>Egger</surname><given-names>M</given-names></name>, <name><surname>Pocock</surname><given-names>SJ</given-names></name>, <name><surname>G&#x000f8;tzsche</surname><given-names>PC</given-names></name>, <name><surname>Vandenbroucke</surname><given-names>JP</given-names></name>, <etal/>
<article-title>The Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies</article-title>. <source>Ann Intern Med</source>
<year>2007</year>;<volume>147</volume>(<issue>8</issue>):<fpage>573</fpage>&#x02013;<lpage>7</lpage>. <month>Oct</month>
<day>16</day>.<pub-id pub-id-type="pmid">17938396</pub-id>
</mixed-citation></ref><ref id="R50"><label>[50]</label><mixed-citation publication-type="journal"><collab>STARD Group</collab>, <name><surname>Bossuyt</surname><given-names>PM</given-names></name>, <name><surname>Reitsma</surname><given-names>JB</given-names></name>, <name><surname>Bruns</surname><given-names>DE</given-names></name>, <name><surname>Gatsonis</surname><given-names>CA</given-names></name>, <name><surname>Glasziou</surname><given-names>PP</given-names></name>, <etal/>
<article-title>STARD 2015 : an updated list of essential items for reporting diagnostic accuracy studies</article-title>. <source>BMJ</source>
<volume>2015</volume>:<fpage>351</fpage>. <month>Oct</month>
<day>28</day>.</mixed-citation></ref><ref id="R51"><label>[51]</label><mixed-citation publication-type="journal"><name><surname>Hopewell</surname><given-names>S</given-names></name>, <name><surname>Chan</surname><given-names>AW</given-names></name>, <name><surname>Collins</surname><given-names>GS</given-names></name>, <name><surname>Hr&#x000f3;bjartsson</surname><given-names>A</given-names></name>, <name><surname>Moher</surname><given-names>D</given-names></name>, <name><surname>Schulz</surname><given-names>KF</given-names></name>, <etal/>
<article-title>CONSORT 2025 statement: updated guideline for reporting randomised trials</article-title>. <source>BMJ</source>
<year>2025</year>;<fpage>389</fpage>. <month>Apr</month>
<day>14</day>. (e081123).</mixed-citation></ref><ref id="R52"><label>[52]</label><mixed-citation publication-type="journal"><name><surname>Collins</surname><given-names>GS</given-names></name>, <name><surname>Moons</surname><given-names>KGM</given-names></name>, <name><surname>Dhiman</surname><given-names>P</given-names></name>, <name><surname>Riley</surname><given-names>RD</given-names></name>, <name><surname>Beam</surname><given-names>AL</given-names></name>, <name><surname>Calster</surname><given-names>BV</given-names></name>, <etal/>
<article-title>TRIPOD+ AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods</article-title>. <source>BMJ</source>
<year>2024</year>;<fpage>385</fpage>. <month>Apr</month>
<day>16</day>. (e078378).</mixed-citation></ref><ref id="R53"><label>[53]</label><mixed-citation publication-type="journal"><name><surname>Moher</surname><given-names>D</given-names></name>, <name><surname>Schulz</surname><given-names>KF</given-names></name>, <name><surname>Simera</surname><given-names>I</given-names></name>, <name><surname>Altman</surname><given-names>DG</given-names></name>. <article-title>Guidance for developers of health research reporting guidelines</article-title>. <source>PLoS Med</source>
<year>2010</year>;<volume>7</volume>(<issue>2</issue>). <month>Feb</month>
<day>16</day>. (e1000217).</mixed-citation></ref><ref id="R54"><label>[54]</label><mixed-citation publication-type="journal"><name><surname>von Elm</surname><given-names>E</given-names></name>, <name><surname>Altman</surname><given-names>DG</given-names></name>, <name><surname>Egger</surname><given-names>M</given-names></name>, <name><surname>Pocock</surname><given-names>SJ</given-names></name>, <name><surname>G&#x000f8;tzsche</surname><given-names>PC</given-names></name>, <name><surname>Vandenbroucke</surname><given-names>JP</given-names></name>. <article-title>The Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies</article-title>. <source>Int J Surg</source>
<year>2014</year>;<volume>12</volume>(<issue>12</issue>): <fpage>1495</fpage>&#x02013;<lpage>9</lpage>. <month>Dec</month>
<day>1</day>.<pub-id pub-id-type="pmid">25046131</pub-id>
</mixed-citation></ref><ref id="R55"><label>[55]</label><mixed-citation publication-type="journal"><name><surname>Schulz</surname><given-names>KF</given-names></name>, <name><surname>Altman</surname><given-names>DG</given-names></name>, <name><surname>Moher</surname><given-names>D</given-names></name>, <article-title>CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials</article-title>. <source>BMJ</source>
<year>2010</year>;<volume>340</volume>. <month>Mar</month>
<day>23</day>. (c332).</mixed-citation></ref><ref id="R56"><label>[56]</label><mixed-citation publication-type="journal"><name><surname>Husereau</surname><given-names>D</given-names></name>, <name><surname>Drummond</surname><given-names>M</given-names></name>, <name><surname>Augustovski</surname><given-names>F</given-names></name>, <name><surname>de Bekker-Grob</surname><given-names>E</given-names></name>, <name><surname>Briggs</surname><given-names>AH</given-names></name>, <name><surname>Carswell</surname><given-names>C</given-names></name>, <etal/>
<article-title>Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations</article-title>. <source>BMC Med</source>
<year>2022</year>;<volume>20</volume>(<issue>1</issue>):<fpage>23</fpage>. <month>Jan</month>
<day>12</day>.<pub-id pub-id-type="pmid">35022047</pub-id>
</mixed-citation></ref><ref id="R57"><label>[57]</label><mixed-citation publication-type="journal"><name><surname>Hsu</surname><given-names>CC</given-names></name>, <name><surname>Sandford</surname><given-names>BA</given-names></name>. <article-title>The Delphi technique: making sense of consensus</article-title>. <source>Pract Assess Res Eval</source>
<year>2007</year>;<volume>12</volume>(<issue>10</issue>):<fpage>1</fpage>&#x02013;<lpage>8</lpage>. <month>Jan</month>
<day>1</day>.</mixed-citation></ref><ref id="R58"><label>[58]</label><mixed-citation publication-type="journal"><name><surname>Vernooij Robin</surname><given-names>WM</given-names></name>, <name><surname>Pablo</surname><given-names>Alonso-Coello</given-names></name>, <name><surname>Melissa</surname><given-names>Brouwers</given-names></name>, <name><surname>Mart&#x000ed;nez</surname><given-names>Garc&#x000ed;a Laura</given-names></name>, CheckUp Panel. <article-title>Reporting items for updated clinical guidelines: checklist for the reporting of updated guidelines (CheckUp)</article-title>. <source>PLoS Med</source>
<year>2017</year>;<volume>14</volume>(<issue>1</issue>). <month>Jan</month>
<day>1</day>. (e1002207&#x02013;e1002207).</mixed-citation></ref><ref id="R59"><label>[59]</label><mixed-citation publication-type="journal"><name><surname>Morrison</surname><given-names>EH</given-names></name>, <name><surname>Sorkin</surname><given-names>D</given-names></name>, <name><surname>Mosqueda</surname><given-names>L</given-names></name>, <name><surname>Ayutyanont</surname><given-names>N</given-names></name>. <article-title>Validity and reliability of the scale to report emotional stress signs-multiple sclerosis (STRESS-MS) in assessing abuse and neglect of adults with multiple sclerosis</article-title>. <source>Int J MS Care</source>
<year>2022</year>;<volume>1</volume>.</mixed-citation></ref><ref id="R60"><label>[60]</label><mixed-citation publication-type="journal"><name><surname>Mackenhauer</surname><given-names>J</given-names></name>, <name><surname>Winsl&#x000f8;v</surname><given-names>JH</given-names></name>, <name><surname>Holmskov</surname><given-names>J</given-names></name>, <name><surname>Br&#x000f8;dsgaard</surname><given-names>I</given-names></name>, <name><surname>Larsen</surname><given-names>TG</given-names></name>, <name><surname>Mainz</surname><given-names>J</given-names></name>. <article-title>Analysis of suicides reported as adverse events in psychiatry resulted in nine quality improvement initiatives</article-title>. <source>Crisis</source>
<year>2022</year>;<volume>43</volume>(<issue>4</issue>):<fpage>307</fpage>&#x02013;<lpage>14</lpage>. <month>Jul</month>.<pub-id pub-id-type="pmid">34003020</pub-id>
</mixed-citation></ref><ref id="R61"><label>[61]</label><mixed-citation publication-type="journal"><name><surname>Hendriks</surname><given-names>E</given-names></name>, <name><surname>Muris</surname><given-names>P</given-names></name>, <name><surname>Meesters</surname><given-names>C</given-names></name>, <name><surname>Houben</surname><given-names>K</given-names></name>. <article-title>Childhood disorder: dysregulated self-conscious emotions? Psychopathological correlates of implicit and explicit shame and guilt in clinical and non-clinical children and adolescents</article-title>. <source>Front Psychol</source>
<year>2022</year>; <volume>13</volume>:<fpage>822725</fpage>.<pub-id pub-id-type="pmid">35356351</pub-id>
</mixed-citation></ref><ref id="R62"><label>[62]</label><mixed-citation publication-type="journal"><name><surname>Paap</surname><given-names>MCS</given-names></name>, <name><surname>Heltne</surname><given-names>A</given-names></name>, <name><surname>Pedersen</surname><given-names>G</given-names></name>, <name><surname>Germans Selvik</surname><given-names>S</given-names></name>, <name><surname>Frans</surname><given-names>N</given-names></name>, <name><surname>Wilberg</surname><given-names>T</given-names></name>, <etal/>
<article-title>More is more: evidence for the incremental value of the SCID-II/SCID-5-PD specific factors over and above a general personality disorder factor</article-title>. <source>Personal Disord</source>
<year>2022</year>; <volume>13</volume>(<issue>2</issue>):<fpage>108</fpage>&#x02013;<lpage>18</lpage>. <month>Mar</month>.<pub-id pub-id-type="pmid">33600207</pub-id>
</mixed-citation></ref><ref id="R63"><label>[63]</label><mixed-citation publication-type="journal"><name><surname>Aydin</surname><given-names>S</given-names></name>, <name><surname>Siebelink</surname><given-names>BM</given-names></name>, <name><surname>Crone</surname><given-names>MR</given-names></name>, <name><surname>van Ginkel</surname><given-names>JR</given-names></name>, <name><surname>Numans</surname><given-names>ME</given-names></name>, <name><surname>Vermeiren</surname><given-names>RRJM</given-names></name>, <etal/>
<article-title>The diagnostic process from primary care to child and adolescent mental healthcare services: the incremental value of information conveyed through referral letters, screening questionnaires and structured multi-informant assessment</article-title>. <source>BJPsych Open</source>
<year>2022</year>;<volume>8</volume>(<issue>3</issue>). <month>Apr</month>
<day>7</day>. (e81).</mixed-citation></ref><ref id="R64"><label>[64]</label><mixed-citation publication-type="journal"><name><surname>Rocha Neto</surname><given-names>HG</given-names></name>, <name><surname>Lessa</surname><given-names>JLM</given-names></name>, <name><surname>Koiller</surname><given-names>LM</given-names></name>, <name><surname>Pereira</surname><given-names>AM</given-names></name>, <name><surname>de Souza Gomes</surname><given-names>BM</given-names></name>, <name><surname>Veloso Filho</surname><given-names>CL</given-names></name>, <etal/>
<article-title>Non-standard diagnostic assessment reliability in psychiatry: a study in a Brazilian outpatient setting using Kappa</article-title>. <source>Eur Arch Psychiatry Clin Neurosci</source>
<year>2024</year>
<month>Oct</month>;<volume>274</volume>(<issue>7</issue>):<fpage>1759</fpage>&#x02013;<lpage>70</lpage>. Epub 2023 Dec 12.<pub-id pub-id-type="pmid">38085328</pub-id>
</mixed-citation></ref><ref id="R65"><label>[65]</label><mixed-citation publication-type="journal"><name><surname>Spangenberg</surname><given-names>H</given-names></name>, <name><surname>Ramklint</surname><given-names>M</given-names></name>, <name><surname>Ramirez</surname><given-names>A</given-names></name>. <article-title>A long-term follow-up study of labor market marginalization in psychiatric patients with and without personality disorder</article-title>. <source>Ups J Med Sci</source>
<year>2023</year>;<volume>128</volume>. <pub-id pub-id-type="doi">10.48101/ujms.v128.9014</pub-id>. <month>Jul</month>
<day>31</day>.</mixed-citation></ref><ref id="R66"><label>[66]</label><mixed-citation publication-type="journal"><name><surname>Muris</surname><given-names>P</given-names></name>, <name><surname>B&#x000fc;ttgens</surname><given-names>L</given-names></name>, <name><surname>Koolen</surname><given-names>M</given-names></name>, <name><surname>Manni&#x000eb;n</surname><given-names>C</given-names></name>, <name><surname>Scholtes</surname><given-names>N</given-names></name>, <name><surname>van Dooren-Theunissen</surname><given-names>W</given-names></name>. <article-title>Symptoms of selective mutism in middle childhood: psychopathological and temperament correlates in Non-clinical and clinically referred 6- to 12-year-old children</article-title>. <source>Child Psychiatry Hum Dev</source>
<year>2024</year>
<month>Dec</month>;<volume>55</volume>(<issue>6</issue>):<fpage>1514</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="pmid">36853426</pub-id>
</mixed-citation></ref><ref id="R67"><label>[67]</label><mixed-citation publication-type="journal"><name><surname>Sveen</surname><given-names>CA</given-names></name>, <name><surname>Pedersen</surname><given-names>G</given-names></name>, <name><surname>Hummelen</surname><given-names>B</given-names></name>, <name><surname>Kvarstein</surname><given-names>EH</given-names></name>. <article-title>Personality disorders: The impact of severity on societal costs</article-title>. <source>Eur Arch Psychiatry Clin Neurosci</source>
<year>2025</year>;<volume>275</volume> (<issue>1</issue>):<fpage>181</fpage>&#x02013;<lpage>92</lpage>. Epub 2023 Nov 22.<pub-id pub-id-type="pmid">37991536</pub-id>
</mixed-citation></ref><ref id="R68"><label>[68]</label><mixed-citation publication-type="journal"><name><surname>Pedersen</surname><given-names>G</given-names></name>, <name><surname>Kvarstein</surname><given-names>EH</given-names></name>, <name><surname>Wilberg</surname><given-names>T</given-names></name>, <name><surname>Folmo</surname><given-names>EJ</given-names></name>, <name><surname>Burlingame</surname><given-names>GM</given-names></name>, <name><surname>Lorentzen</surname><given-names>S</given-names></name>. <article-title>The group questionnaire (GQ)&#x02014;psychometric properties among outpatients with personality disorders</article-title>. <source>Group Dyn Theory Res Pract</source>
<year>2023</year>;<volume>27</volume>(<issue>2</issue>):<fpage>81</fpage>&#x02013;<lpage>98</lpage>.</mixed-citation></ref><ref id="R69"><label>[69]</label><mixed-citation publication-type="journal"><name><surname>Sadleir</surname><given-names>PHM</given-names></name>, <name><surname>Clarke</surname><given-names>RC</given-names></name>, <name><surname>Goddard</surname><given-names>CE</given-names></name>, <name><surname>Mickle</surname><given-names>P</given-names></name>, <name><surname>Platt</surname><given-names>PR</given-names></name>. <article-title>Agreement of a clinical scoring system with allergic anaphylaxis in suspected perioperative hypersensitivity reactions: prospective validation of a new tool</article-title>. <source>Br J Anaesth</source>
<year>2022</year>; <volume>129</volume>(<issue>5</issue>):<fpage>670</fpage>&#x02013;<lpage>8</lpage>. <month>Nov</month>.<pub-id pub-id-type="pmid">36085094</pub-id>
</mixed-citation></ref><ref id="R70"><label>[70]</label><mixed-citation publication-type="journal"><name><surname>Khan</surname><given-names>AM</given-names></name>, <name><surname>Ahmed</surname><given-names>S</given-names></name>, <name><surname>Chowdhury</surname><given-names>NH</given-names></name>, <name><surname>Islam</surname><given-names>MS</given-names></name>, <name><surname>McCollum</surname><given-names>ED</given-names></name>, <name><surname>King</surname><given-names>C</given-names></name>, <etal/>
<article-title>Developing a video expert panel as a reference standard to evaluate respiratory rate counting in paediatric pneumonia diagnosis: protocol for a cross-sectional study</article-title>. <source>BMJ Open</source>
<year>2022</year>;<volume>12</volume>(<issue>11</issue>). <month>Nov</month>
<day>15</day>. (e067389).</mixed-citation></ref><ref id="R71"><label>[71]</label><mixed-citation publication-type="journal"><name><surname>Loots</surname><given-names>FJ</given-names></name>, <name><surname>Smits</surname><given-names>M</given-names></name>, <name><surname>Hopstaken</surname><given-names>RM</given-names></name>, <name><surname>Jenniskens</surname><given-names>K</given-names></name>, <name><surname>Schroeten</surname><given-names>FH</given-names></name>, <name><surname>van den Bruel</surname><given-names>A</given-names></name>, <etal/>
<article-title>New clinical prediction model for early recognition of sepsis in adult primary care patients: a prospective diagnostic cohort study of development and external validation</article-title>. <source>Br J Gen Pract J R Coll Gen Pract</source>
<year>2022</year>;<volume>72</volume>(<issue>719</issue>):<fpage>e437</fpage>&#x02013;<lpage>45</lpage>. <month>Jun</month>.</mixed-citation></ref><ref id="R72"><label>[72]</label><mixed-citation publication-type="journal"><name><surname>Leroux</surname><given-names>A</given-names></name>, <name><surname>Frey</surname><given-names>KP</given-names></name>, <name><surname>Crainiceanu</surname><given-names>CM</given-names></name>, <name><surname>Obremskey</surname><given-names>WT</given-names></name>, <name><surname>Stinner</surname><given-names>DJ</given-names></name>, <name><surname>Bosse</surname><given-names>MJ</given-names></name>, <etal/>
<article-title>Defining incidence of acute compartment syndrome in the research setting: a proposed method from the PACS study</article-title>. <source>J Orthop Trauma</source>
<year>2022</year>;<volume>36</volume>(<issue>Suppl. 1</issue>): <fpage>S26</fpage>&#x02013;<lpage>32</lpage>. <month>Jan</month>
<day>1</day>.</mixed-citation></ref><ref id="R73"><label>[73]</label><mixed-citation publication-type="journal"><name><surname>Kocks</surname><given-names>JWH</given-names></name>, <name><surname>Cao</surname><given-names>H</given-names></name>, <name><surname>Holzhauer</surname><given-names>B</given-names></name>, <name><surname>Kaplan</surname><given-names>A</given-names></name>, <name><surname>FitzGerald</surname><given-names>JM</given-names></name>, <name><surname>Kostikas</surname><given-names>K</given-names></name>, <etal/>
<article-title>Diagnostic performance of a machine learning algorithm (asthma/chronic obstructive pulmonary disease [COPD] differentiation classification) tool versus primary care physicians and pulmonologists in asthma, COPD, and asthma/COPD overlap</article-title>. <source>J Allergy Clin Immunol Pract</source>
<year>2023</year>;<volume>11</volume>(<issue>5</issue>):<fpage>1463</fpage>&#x02013;<lpage>1474</lpage>.e3. <month>May</month>
<day>1</day>.<pub-id pub-id-type="pmid">36716998</pub-id>
</mixed-citation></ref><ref id="R74"><label>[74]</label><mixed-citation publication-type="journal"><name><surname>Lacroix</surname><given-names>L</given-names></name>, <name><surname>Papis</surname><given-names>S</given-names></name>, <name><surname>Mardegan</surname><given-names>C</given-names></name>, <name><surname>Luterbacher</surname><given-names>F</given-names></name>, <name><surname>L&#x02019;Huillier</surname><given-names>A</given-names></name>, <name><surname>Sahyoun</surname><given-names>C</given-names></name>, <etal/>
<article-title>Host biomarkers and combinatorial scores for the detection of serious and invasive bacterial infection in pediatric patients with fever without source</article-title>. <source>PloS One</source>
<year>2023</year>; <volume>18</volume>(<issue>11</issue>):<fpage>e0294032</fpage>.<pub-id pub-id-type="pmid">37956117</pub-id>
</mixed-citation></ref><ref id="R75"><label>[75]</label><mixed-citation publication-type="journal"><name><surname>Nienhuis</surname><given-names>PH</given-names></name>, <name><surname>van Nieuwland</surname><given-names>M</given-names></name>, <name><surname>van Praagh</surname><given-names>GD</given-names></name>, <name><surname>Markusiewicz</surname><given-names>K</given-names></name>, <name><surname>Colin</surname><given-names>EM</given-names></name>, <name><surname>van der Geest</surname><given-names>KSM</given-names></name>, <etal/>
<article-title>Comparing diagnostic performance of short and long [18F] FDG-PET acquisition times in giant cell arteritis</article-title>. <source>Diagn Basel Switz</source>
<year>2023</year>;<volume>14</volume>(<issue>1</issue>):<fpage>62</fpage>. <month>Dec</month>
<day>27</day>.</mixed-citation></ref><ref id="R76"><label>[76]</label><mixed-citation publication-type="journal"><name><surname>Himmelreich</surname><given-names>JCL</given-names></name>, <name><surname>Harskamp</surname><given-names>RE</given-names></name>. <article-title>Diagnostic accuracy of the PMcardio smartphone application for artificial intelligence&#x02013;based interpretation of electrocardiograms in primary care (AMSTELHEART-1)</article-title>. <source>Cardiovasc Digit Health J</source>
<year>2023</year>;<volume>4</volume>(<issue>3</issue>):<fpage>80</fpage>&#x02013;<lpage>90</lpage>. <month>Jun</month>
<day>1</day>.<pub-id pub-id-type="pmid">37351331</pub-id>
</mixed-citation></ref><ref id="R77"><label>[77]</label><mixed-citation publication-type="journal"><name><surname>de la Matta</surname><given-names>M</given-names></name>, <name><surname>Alonso-Gonz&#x000e1;lez</surname><given-names>M</given-names></name>, <name><surname>Garc&#x000ed;a-Santigosa</surname><given-names>M</given-names></name>, <name><surname>Arance-Garc&#x000ed;a</surname><given-names>M</given-names></name>, <name><surname>S&#x000e1;nchez-Pe&#x000f1;a</surname><given-names>J</given-names></name>, <name><surname>Castro-Li&#x000f1;&#x000e1;n</surname><given-names>LM</given-names></name>, <etal/>
<article-title>Accuracy and comprehensiveness in recording information of a web-based application for preoperative assessment: a prospective observational study</article-title>. <source>J Perianesth Nurs</source>
<year>2023</year>;<volume>38</volume>(<issue>3</issue>):<fpage>440</fpage>&#x02013;<lpage>7</lpage>. <month>Jun</month>
<day>1</day>.<pub-id pub-id-type="pmid">36509667</pub-id>
</mixed-citation></ref><ref id="R78"><label>[78]</label><mixed-citation publication-type="journal"><name><surname>Peterson</surname><given-names>BS</given-names></name>, <name><surname>Kaur</surname><given-names>T</given-names></name>, <name><surname>Baez</surname><given-names>MA</given-names></name>, <name><surname>Whiteman</surname><given-names>RC</given-names></name>, <name><surname>Sawardekar</surname><given-names>S</given-names></name>, <name><surname>Sanchez-Pe&#x000f1;a</surname><given-names>J</given-names></name>, <etal/>
<article-title>Morphological biomarkers in the amygdala and Hippocampus of children and adults at high familial risk for depression</article-title>. <source>Diagnostics</source>
<year>2022</year>;<volume>12</volume>(<issue>5</issue>):<fpage>1218</fpage>. <month>May</month>.<pub-id pub-id-type="pmid">35626374</pub-id>
</mixed-citation></ref><ref id="R79"><label>[79]</label><mixed-citation publication-type="journal"><name><surname>Reiersen</surname><given-names>AM</given-names></name>, <name><surname>Noel</surname><given-names>JS</given-names></name>, <name><surname>Doty</surname><given-names>T</given-names></name>, <name><surname>Sinkre</surname><given-names>RA</given-names></name>, <name><surname>Narayanan</surname><given-names>A</given-names></name>, <name><surname>Hershey</surname><given-names>T</given-names></name>. <article-title>Psychiatric diagnoses and medications in Wolfram syndrome</article-title>. <source>Scand J Child Adolesc Psychiatry Psychol</source>
<year>2022</year>;<volume>10</volume>(<issue>1</issue>):<fpage>163</fpage>&#x02013;<lpage>74</lpage>. <month>Jan</month>.</mixed-citation></ref><ref id="R80"><label>[80]</label><mixed-citation publication-type="journal"><name><surname>Bradshaw</surname><given-names>J</given-names></name>, <name><surname>Shi</surname><given-names>D</given-names></name>, <name><surname>Hendrix</surname><given-names>CL</given-names></name>, <name><surname>Saulnier</surname><given-names>C</given-names></name>, <name><surname>Klaiman</surname><given-names>C</given-names></name>. <article-title>Neonatal neurobehavior in infants with autism spectrum disorder</article-title>. <source>Dev Med Child Neurol</source>
<year>2022</year>;<volume>64</volume>(<issue>5</issue>):<fpage>600</fpage>&#x02013;<lpage>7</lpage>. <month>May</month>.<pub-id pub-id-type="pmid">34713902</pub-id>
</mixed-citation></ref><ref id="R81"><label>[81]</label><mixed-citation publication-type="journal"><name><surname>Hesam-Shariati</surname><given-names>S</given-names></name>, <name><surname>Overs</surname><given-names>BJ</given-names></name>, <name><surname>Roberts</surname><given-names>G</given-names></name>, <name><surname>Toma</surname><given-names>C</given-names></name>, <name><surname>Watkeys</surname><given-names>OJ</given-names></name>, <name><surname>Green</surname><given-names>MJ</given-names></name>, <etal/>
<article-title>Epigenetic signatures relating to disease-associated genotypic burden in familial risk of bipolar disorder</article-title>. <source>Transl Psychiatry</source>
<year>2022</year>;<volume>12</volume>(<issue>1</issue>):<fpage>310</fpage>. <month>Aug</month>
<day>3</day>.<pub-id pub-id-type="pmid">35922419</pub-id>
</mixed-citation></ref><ref id="R82"><label>[82]</label><mixed-citation publication-type="journal"><name><surname>Shima</surname><given-names>C</given-names></name>, <name><surname>Lee</surname><given-names>R</given-names></name>, <name><surname>Coccaro</surname><given-names>EF</given-names></name>. <article-title>Associations of agression and use of caffeine, alcohol and nicotine in healthy and aggressive individuals</article-title>. <source>J Psychiatr Res</source>
<year>2022</year>;<volume>146</volume>:<fpage>21</fpage>&#x02013;<lpage>7</lpage>. <month>Feb</month>.<pub-id pub-id-type="pmid">34942448</pub-id>
</mixed-citation></ref><ref id="R83"><label>[83]</label><mixed-citation publication-type="journal"><name><surname>Kvig</surname><given-names>EI</given-names></name>, <name><surname>Nilssen</surname><given-names>S</given-names></name>. <article-title>Does method matter? Assessing the validity and clinical utility of structured diagnostic interviews among a clinical sample of first-admitted patients with psychosis: a replication study</article-title>. <source>Front Psych</source>
<year>2023</year>;<volume>14</volume>:<fpage>1076299</fpage>.</mixed-citation></ref><ref id="R84"><label>[84]</label><mixed-citation publication-type="journal"><name><surname>Detera-Wadleigh</surname><given-names>SD</given-names></name>, <name><surname>Kassem</surname><given-names>L</given-names></name>, <name><surname>Besancon</surname><given-names>E</given-names></name>, <name><surname>Lopes</surname><given-names>F</given-names></name>, <name><surname>Akula</surname><given-names>N</given-names></name>, <name><surname>Sung</surname><given-names>H</given-names></name>, <etal/>
<article-title>A resource of induced pluripotent stem cell (iPSC) lines including clinical, genomic, and cellular data from genetically isolated families with mood and psychotic disorders</article-title>. <source>Transl Psychiatry</source>
<year>2023</year>;<volume>13</volume>(<issue>1</issue>):<fpage>397</fpage>. <month>Dec</month>
<day>16</day>.<pub-id pub-id-type="pmid">38104115</pub-id>
</mixed-citation></ref><ref id="R85"><label>[85]</label><mixed-citation publication-type="journal"><name><surname>Hill</surname><given-names>SY</given-names></name>, <name><surname>Hostyk</surname><given-names>J</given-names></name>. <article-title>A whole exome sequencing study to identify rare variants in multiplex families with alcohol use disorder</article-title>. <source>Front Psychiatry</source>. <year>2023</year>;<volume>14</volume>:<fpage>1216493</fpage>. <month>Oct</month>
<day>17</day>.<pub-id pub-id-type="pmid">37915799</pub-id>
</mixed-citation></ref><ref id="R86"><label>[86]</label><mixed-citation publication-type="journal"><name><surname>Jones</surname><given-names>W</given-names></name>, <name><surname>Klaiman</surname><given-names>C</given-names></name>, <name><surname>Richardson</surname><given-names>S</given-names></name>, <name><surname>Lambha</surname><given-names>M</given-names></name>, <name><surname>Reid</surname><given-names>M</given-names></name>, <name><surname>Hamner</surname><given-names>T</given-names></name>, <etal/>
<article-title>Development and replication of objective measurements of social visual engagement to aid in early diagnosis and assessment of autism</article-title>. <source>JAMA Netw Open</source>
<year>2023</year>;<volume>6</volume>(<issue>9</issue>). <month>Sep</month>
<day>5</day>. (e2330145).</mixed-citation></ref><ref id="R87"><label>[87]</label><mixed-citation publication-type="journal"><name><surname>Dimian</surname><given-names>AF</given-names></name>, <name><surname>Estes</surname><given-names>AM</given-names></name>, <name><surname>Dager</surname><given-names>S</given-names></name>, <name><surname>Piven</surname><given-names>J</given-names></name>, <name><surname>Wolff</surname><given-names>JJ</given-names></name>. <article-title>Network for the I. Predicting self-injurious behavior at age three among infant siblings of children with autism</article-title>. <source>Autism Res</source>
<year>2023</year>;<volume>16</volume>(<issue>9</issue>):<fpage>1670</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="pmid">37439184</pub-id>
</mixed-citation></ref><ref id="R88"><label>[88]</label><mixed-citation publication-type="journal"><name><surname>Korevaar</surname><given-names>DA</given-names></name>, <name><surname>Cohen</surname><given-names>JF</given-names></name>, <name><surname>Reitsma</surname><given-names>JB</given-names></name>, <name><surname>Bruns</surname><given-names>DE</given-names></name>, <name><surname>Gatsonis</surname><given-names>CA</given-names></name>, <name><surname>Glasziou</surname><given-names>PP</given-names></name>, <etal/>
<article-title>Updating standards for reporting diagnostic accuracy: the development of STARD 2015</article-title>. <source>Res Integr Peer Rev</source>
<year>2016</year>;<volume>1</volume>(<issue>1</issue>):<fpage>7</fpage>. <month>Jun</month>
<day>7</day>.<pub-id pub-id-type="pmid">29451535</pub-id>
</mixed-citation></ref><ref id="R89"><label>[89]</label><mixed-citation publication-type="journal"><name><surname>Collins</surname><given-names>GS</given-names></name>, <name><surname>Reitsma</surname><given-names>JB</given-names></name>, <name><surname>Altman</surname><given-names>DG</given-names></name>, <name><surname>Moons</surname><given-names>KGM</given-names></name>. <article-title>Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement</article-title>. <source>BMJ</source>
<year>2015</year>;<volume>350</volume>. <month>Jan</month>
<day>7</day>. (g7594).</mixed-citation></ref><ref id="R90"><label>[90]</label><mixed-citation publication-type="journal"><name><surname>Blanco</surname><given-names>D</given-names></name>, <name><surname>Altman</surname><given-names>D</given-names></name>, <name><surname>Moher</surname><given-names>D</given-names></name>, <name><surname>Boutron</surname><given-names>I</given-names></name>, <name><surname>Kirkham</surname><given-names>JJ</given-names></name>, <name><surname>Cobo</surname><given-names>E</given-names></name>. <article-title>Scoping review on interventions to improve adherence to reporting guidelines in health research</article-title>. <source>BMJ Open</source>
<year>2019</year>;<volume>9</volume>(<issue>5</issue>). <month>May</month>
<day>9</day>. (e026589).</mixed-citation></ref><ref id="R91"><label>[91]</label><mixed-citation publication-type="journal"><name><surname>Samaan</surname><given-names>Z</given-names></name>, <name><surname>Mbuagbaw</surname><given-names>L</given-names></name>, <name><surname>Kosa</surname><given-names>D</given-names></name>, <name><surname>Debono</surname><given-names>VB</given-names></name>, <name><surname>Dillenburg</surname><given-names>R</given-names></name>, <name><surname>Zhang</surname><given-names>S</given-names></name>, <etal/>
<article-title>A systematic scoping review of adherence to reporting guidelines in health care literature</article-title>. <source>J Multidiscip Healthc</source>
<year>2013</year>;<volume>6</volume>(<issue>6</issue>):<fpage>169</fpage>&#x02013;<lpage>88</lpage>. <month>May</month>.<pub-id pub-id-type="pmid">23671390</pub-id>
</mixed-citation></ref><ref id="R92"><label>[92]</label><mixed-citation publication-type="journal"><name><surname>Heus</surname><given-names>P</given-names></name>, <name><surname>Damen</surname><given-names>JAAG</given-names></name>, <name><surname>Pajouheshnia</surname><given-names>R</given-names></name>, <name><surname>Scholten</surname><given-names>RJPM</given-names></name>, <name><surname>Reitsma</surname><given-names>JB</given-names></name>, <name><surname>Collins</surname><given-names>GS</given-names></name>, <etal/>
<article-title>Uniformity in measuring adherence to reporting guidelines: the example of TRIPOD for assessing completeness of reporting of prediction model studies</article-title>. <source>BMJ Open</source>
<year>2019</year>;<volume>9</volume>(<issue>4</issue>). <month>Apr</month>
<day>1</day>. (e025611).</mixed-citation></ref><ref id="R93"><label>[93]</label><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>Z</given-names></name>, <name><surname>Luo</surname><given-names>X</given-names></name>, <name><surname>Yang</surname><given-names>Z</given-names></name>, <name><surname>Zhang</surname><given-names>H</given-names></name>, <name><surname>Wang</surname><given-names>B</given-names></name>, <name><surname>Ge</surname><given-names>L</given-names></name>, <etal/>
<article-title>RAPID: Reliable and efficient Automatic generation of submission rePorting checklists with Large language moDels</article-title>. <source>bioRxiv</source>
<year>2025</year>. p. 2025.02.13.638015.</mixed-citation></ref><ref id="R94"><label>[94]</label><mixed-citation publication-type="journal"><name><surname>Wrightson</surname><given-names>JG</given-names></name>, <name><surname>Blazey</surname><given-names>P</given-names></name>, <name><surname>Moher</surname><given-names>D</given-names></name>, <name><surname>Khan</surname><given-names>KM</given-names></name>, <name><surname>Ardern</surname><given-names>CL</given-names></name>. <article-title>GPT for RCTs?: Using AI to determine adherence to reporting guidelines</article-title>. <source>medRxiv</source>
<year>2024</year>. p. 2023.12.14.23299971.</mixed-citation></ref></ref-list></back><floats-group><fig position="float" id="F1"><label>Fig. 1.</label><caption><p id="P58">Research experiences and demographics of the Delphi participants.</p><p id="P59"><italic toggle="yes">Notes.</italic> The answer options for Academic backgrounds and Methodological experiences were not mutually exclusive (i.e., multiple backgrounds and experiences could be reported by the participants). In Round 2, the demographics and reported experiences are known for 17 of the 20 participants.</p></caption><graphic xlink:href="nihms-2112058-f0001" position="float"/></fig><fig position="float" id="F2"><label>Fig. 2.</label><caption><p id="P60">Overview of the LEADING guideline reporting standards. For more details about each standard, see <xref rid="T1" ref-type="table">Table 1</xref>.</p></caption><graphic xlink:href="nihms-2112058-f0002" position="float"/></fig><table-wrap position="float" id="T1" orientation="landscape"><label>Table 1</label><caption><p id="P61">The LEADING guideline reporting standards.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Group</th><th align="center" valign="top" rowspan="1" colspan="1">#</th><th align="left" valign="top" rowspan="1" colspan="1">Reporting standards</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Longitudinal Design</td><td align="left" valign="top" rowspan="1" colspan="1">1.1</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>The time period</bold>. The data collection period covered for each participant (i.e., start and end of the data collection) and to what extent the length is sufficient for capturing the targeted symptoms.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<italic toggle="yes">Report the longitudinal design, by describing:</italic></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">For example, the weeks/months a participant is followed and how this matches the criteria for the targeted disease/disorder.</italic>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">1.2</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>The number of time points</bold>. Whether and how data were collected on multiple occasions between the start and the end of the time period, the sufficiency of the data collection, and of its frequency and intensity for capturing the target.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">For example, report the number of check-ins with the participants and the included measures for each assessment.</italic>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">1.3</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>History or lifetime information</bold>. Whether and which data from before the start of the data collection were taken into account and how these data are relevant for the assessment of the target.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">History or lifetime data may include self-report of medical history, childhood memory accounts, or other-than-self information such as from relatives or from medical records.</italic>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">1.4</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>The targeted time point(s) of the experts' assessment</bold>. The time point(s) for which the experts provide their assessment, on which time period the data of the assessments are based (i.e., past data, future data, or both), and justifications for the targeted time point(s).</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">For example, the experts can assess the presence of a diagnosis at the start of the study and thus base their assessment on future data from that reference point; or in the middle of the study time period and thus have access to both past and future data from that reference point.</italic>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Appropriate data</td><td align="left" valign="top" rowspan="1" colspan="1">2.1</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>The type and quality of the data.</bold> The type, quality, and relevance of the data and why these data sources are sufficient and suitable for capturing the target.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<italic toggle="yes">Report the appropriate-ness of the data, by describing:</italic></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">For example, describe the validity and reliability of the data</italic> &#x02013; <italic toggle="yes">and how it relates to capturing the targeted construct.</italic></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">2.2</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>The data triangulation.</bold> Whether and why the data come from different methodological approaches and the degree to which these approaches complement each other.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">For example, how self-reported data is complemented by objective/physical tests and/or other informant data.</italic>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">2.3</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>The data presentation</bold>. How the data were structured and presented to the experts for their assessments and why.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">For example, were the data presented in a case report; and was the information presented with or without any interpretation?</italic>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">2.4</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>The access to the index measure</bold>. For an assessment accuracy study, the extent the experts had access to the index measure and why (i.e., an assessment that is being compared to the best-estimate assessment), and how its information was weighted in their assessment.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">For example, were experts blind to the measure (its outcome and/or its raw data) that is being validated?</italic>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Evaluation &#x02013; experts, materials and procedures</td><td align="left" valign="top" rowspan="1" colspan="1">3.1</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>The expert and panel characteristics.</bold> The characteristics of the experts and the panel, as well as how these characteristics are relevant for assessing the target.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<italic toggle="yes">Report the evaluation experts, materials and procedures, by describing:</italic></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Relevant characteristics may include clinical and research experiences, professions, education, and demographics.</italic>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">3.2</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>The number of experts and panels.</bold> The total number of experts and panels, and how many experts/panels were assessing each case and why.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">For example, how many and are the same expert(s)/expertise(s) present in every assessment?</italic>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">3.3</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Blindness and conflicts of interest.</bold> Whether and to what extent the experts are blind to the research aims and/or have any conflicts of interest.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">This may include experts' study authorship or the experts' relationship to the index measure or any other assessment method. If the study examines an index measure (</italic>i.e.<italic toggle="yes">, an assessment that is being compared with the best-estimate assessment), declare the authors' as well as the experts' relationship to it.</italic></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">3.4</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Instructions and training.</bold> The instructions, training, and/or preparation that the experts specifically received for this assessment task and why they did or did not receive this.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">For example, provide information regarding 1) whether the assessment method and procedure are kept standardized across the individual assessments, 2) the methods to ensure experts' preparedness for the assessment, or 3) any specific measures to limit biases.</italic>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">3.5</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>The assessment procedure.</bold> The procedure that the experts followed for their assessment.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">For example, describe whether there was a standardized procedure and what this procedure included (such as following clear diagnostic criteria).</italic>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">3.6</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>The assessment response format.</bold> The response format used by the experts for their individual assessments, what it included, and how it was structured.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">For example, describe any assessment sheet, including assessment questions and answer options.</italic>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">3.7</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>The data combination method.</bold> The method or guidelines for how the data should be weighted, judged, and combined by the individual experts to reach a conclusion in their individual assessment.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">For example, should any data sources be evaluated first or weighted more strongly; or are the experts asked to assess certain diagnostic criteria/symptoms first, before forming a final diagnosis?</italic>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">3.8</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Independent expert assessments.</bold> Whether and how the experts first evaluated the data individually and made their first individual assessments independently.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">For example, how it was ensured the experts first reviewed the data individually/independently before discussing their assessment outcome with the other panel members.</italic>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">3.9</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>The inter-rater and inter-panel reliability.</bold> The inter-rater/inter-panel reliability, how it was calculated and evaluated, or why it was not possible to calculate it.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">For example, which reliability metric was used and over how many experts/panels and cases the reliability was calculated.</italic>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">3.10</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>The solution to disagreements.</bold> The approach for solving (any) disagreements between the individual expert assessments, the rationale for the chosen approach, and potential problems that may have occurred and how these were assessed.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Methods may include reaching a consensus, taking the average, or majority vote. Potential problems may, for example, include power imbalances in the expert panel.</italic>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Validity</td><td align="left" valign="top" rowspan="1" colspan="1">4.1</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>The assessment description.</bold> Description of <italic toggle="yes">what</italic> the assessment actually is.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<italic toggle="yes">Report what was assessed and how well, by describing:</italic></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">For example, is the assessment a diagnosis, symptom severity assessment, course of illness assessment, or treatment response assessment?</italic>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">4.2</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>The validity and standard.</bold> Reflect on the degree of validity and describe the standard that the method aims to achieve, <italic toggle="yes">how</italic> well the assessment method measures up to that degree, and how it compares with current standards.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">For example, reflect on evidence supporting or against validity aspects such as construct, face, and criterion validity; and state whether the assessment should be seen as a best-estimate assessment standard or an accepted reference standard (see</italic>
<xref rid="SD1" ref-type="supplementary-material">Table S2</xref>
<italic toggle="yes">for more examples).</italic></td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p id="P62"><italic toggle="yes">Instructions.</italic> The LEADING guideline comprises these 20 reporting standards for comprehensive reporting of assessment methods involving expert(s) reviewing several sources of information (over time) to achieve a more accurate assessment (e.g., see Expert Panel, Best-Estimate diagnosis, and Longitudinal Expert All Data methods). The standards aim to help researchers plan and report studies employing these assessment methods, as well as help readers evaluate them. As such, avoid simply answering yes or no to the standards when you instead can (succinctly) <italic toggle="yes">describe</italic> justifications and courses of action. Ensure the reports of the standards are clear, specific, and justified. To exemplify, standard <italic toggle="yes">1.1 The time period</italic> could be reported as &#x02018;<italic toggle="yes">The time span was six weeks, which covers more than the two weeks a person should have the symptoms for meeting the criteria for Major Depressive Disorder according to the DSM-5.</italic>&#x02019;</p></fn><fn id="TFN2"><p id="P63">Not all of the reporting standards will be applicable to all types of studies &#x02013; however, it is typically better to describe how a standard is not applicable than to leave the information out. Since the guideline covers the reporting of the assessment method, the method section would suit the reporting of most standards in most cases. However, the reporting guideline does <italic toggle="yes">not</italic> standardize where standards should be reported. When standards are considered less relevant or not applicable to a specific study, they can, for example, be described in an Appendix. Since the guideline focuses specifically on the reporting of the assessment method, it is recommended to use a complementary guideline for the reporting of the other study components. Which complementary guideline is dependent on the study type in which the assessment method is employed (e.g., see STARD for diagnostic accuracy studies; STROBE for observational studies; and CONSORT for randomized trials).</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T2"><label>Table 2</label><caption><p id="P64">Reports across the LEADING guideline standards in 30 randomly selected articles published in 2022 and 2023</p></caption><table frame="void" rules="none"><colgroup span="1"><col align="left" valign="middle" span="1"/></colgroup><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">
<graphic xlink:href="nihms-2112058-t0003" position="float"/>
</td></tr></tbody></table><table-wrap-foot><fn id="TFN3"><p id="P65"><italic toggle="yes">Notes</italic>. red = not reported; orange = insufficiently reported; green = (minimally) sufficiently reported; gray = not applicable to report.</p></fn><fn id="TFN4"><label>1</label><p id="P66">= mean of reporting standards</p></fn><fn id="TFN5"><label>2</label><p id="P67">= mean of studies.</p></fn><fn id="TFN6"><label>*</label><p id="P68">Ten articles for each assessment method were randomly selected (see <xref rid="SD1" ref-type="supplementary-material">SM</xref> for selection process): 1 [<xref rid="R59" ref-type="bibr">59</xref>]; 2 [<xref rid="R60" ref-type="bibr">60</xref>]; 3 [<xref rid="R61" ref-type="bibr">61</xref>]; 4 [<xref rid="R62" ref-type="bibr">62</xref>]; 5 [<xref rid="R63" ref-type="bibr">63</xref>]; 6 [<xref rid="R64" ref-type="bibr">64</xref>]; 7 [<xref rid="R65" ref-type="bibr">65</xref>]; 8 [<xref rid="R66" ref-type="bibr">66</xref>]; 9 [<xref rid="R67" ref-type="bibr">67</xref>]; 10 [<xref rid="R68" ref-type="bibr">68</xref>]; 11 [<xref rid="R69" ref-type="bibr">69</xref>]; 12 [<xref rid="R70" ref-type="bibr">70</xref>]; 13 [<xref rid="R45" ref-type="bibr">45</xref>]; 14 [<xref rid="R71" ref-type="bibr">71</xref>]; 15 [<xref rid="R72" ref-type="bibr">72</xref>]; 16 [<xref rid="R73" ref-type="bibr">73</xref>]; 17 [<xref rid="R74" ref-type="bibr">74</xref>]; 18 [<xref rid="R75" ref-type="bibr">75</xref>]; 19 [<xref rid="R76" ref-type="bibr">76</xref>]; 20 [<xref rid="R77" ref-type="bibr">77</xref>]; 21 [<xref rid="R78" ref-type="bibr">78</xref>]; 22 [<xref rid="R79" ref-type="bibr">79</xref>]; 23 [<xref rid="R80" ref-type="bibr">80</xref>]; 24 [<xref rid="R81" ref-type="bibr">81</xref>]; 25 [<xref rid="R82" ref-type="bibr">82</xref>]; 26 [<xref rid="R83" ref-type="bibr">83</xref>]; 27 [<xref rid="R84" ref-type="bibr">84</xref>]; 28 [<xref rid="R85" ref-type="bibr">85</xref>]; 29 [<xref rid="R86" ref-type="bibr">86</xref>]; 30 [<xref rid="R87" ref-type="bibr">87</xref>]. The 30 articles cover different disciplines and fields, including Clinical Psychology or Psychiatry (19 articles; 63%), Medicine (8 articles; 27%), and Artificial Intelligence (3 articles; 10%).</p></fn></table-wrap-foot></table-wrap><boxed-text id="BX1" position="float"><caption><title>Box 1 Overview of applications of the assessment methods across different study designs and fields</title></caption><p id="P69">The absence of a single error-free measure can be mitigated by involving multiple experts reviewing several sources of information to form a best-estimate assessment. This assessment method is used across clinical fields, such as clinical psychology, psychiatry, medicine, and epidemiology. The use cases below highlight different study designs and fields where the assessment methods are applied. For example, best-estimate assessments are used:</p><list list-type="order" id="L2"><list-item><p id="P70"><bold>To evaluate a measure's accuracy against a reference standard.</bold> To understand the accuracy of a measurement tool, there is a need to compare it to a more accurate or best-estimate assessment. For example, it has been used:
<list list-type="bullet" id="L4"><list-item><p id="P71"><italic toggle="yes">in psychiatry</italic>, for evaluating MINI-KID diagnoses for children and adolescents [<xref rid="R21" ref-type="bibr">21</xref>] <italic toggle="yes">and</italic> evaluating DSM diagnoses in patients with psychosis [<xref rid="R22" ref-type="bibr">22</xref>].</p></list-item><list-item><p id="P72"><italic toggle="yes">in clinical psychology</italic>, for evaluating Major Depression Inventory severity scores [<xref rid="R23" ref-type="bibr">23</xref>].</p></list-item><list-item><p id="P73"><italic toggle="yes">in medicine</italic>, for evaluating deep learning models assessing liver cancer [<xref rid="R24" ref-type="bibr">24</xref>] <italic toggle="yes">and</italic> evaluating prediction rules for coronary artery disease [<xref rid="R25" ref-type="bibr">25</xref>].</p></list-item><list-item><p id="P74"><italic toggle="yes">in epidemiology</italic>, for evaluating electronic health record algorithms for assessing asthma [<xref rid="R26" ref-type="bibr">26</xref>].</p></list-item></list></p></list-item><list-item><p id="P75"><bold>To establish the prevalence of symptoms or disorders.</bold> For example, it has been used:
<list list-type="bullet" id="L6"><list-item><p id="P76"><italic toggle="yes">in epidemiology</italic>, for assessing the prevalence of pathological gambling [<xref rid="R27" ref-type="bibr">27</xref>].</p></list-item><list-item><p id="P77"><italic toggle="yes">in psychiatry</italic>, for assessing the prevalence of eating disorders in personality disorder patients [<xref rid="R28" ref-type="bibr">28</xref>].</p></list-item><list-item><p id="P78"><italic toggle="yes">in medicine</italic>, for assessing the prevalence of clinically relevant findings when diagnosing pulmonary embolism [<xref rid="R29" ref-type="bibr">29</xref>].</p></list-item></list></p></list-item><list-item><p id="P79"><bold>To establish the temporal stability or development of symptoms or disorders.</bold> For example, it has been used:
<list list-type="bullet" id="L8"><list-item><p id="P80"><italic toggle="yes">in clinical psychology</italic>, for learning about autism spectrum disorder diagnoses during childhood [<xref rid="R30" ref-type="bibr">30</xref>] <italic toggle="yes">and</italic> for learning about the course of bipolar disorder [<xref rid="R31" ref-type="bibr">31</xref>].</p></list-item><list-item><p id="P81"><italic toggle="yes">in psychiatry</italic>, for assessing diagnostic stability in individuals with autism spectrum disorder [<xref rid="R32" ref-type="bibr">32</xref>].</p></list-item></list></p></list-item><list-item><p id="P82"><bold>To improve (earlier) detection or screening of symptoms or disorders</bold>. For example, it has been used:
<list list-type="bullet" id="L10"><list-item><p id="P83"><italic toggle="yes">in psychiatry</italic>, for assessing personality disorders [<xref rid="R33" ref-type="bibr">33</xref>].</p></list-item><list-item><p id="P84"><italic toggle="yes">in medicine</italic>, for the early detection of heart failure [<xref rid="R35" ref-type="bibr">35</xref>] <italic toggle="yes">and</italic> for early detection of injuries in physically abused older adults [<xref rid="R34" ref-type="bibr">34</xref>].</p></list-item></list></p></list-item><list-item><p id="P85"><bold>To study genetic history and family heritability.</bold> For example, it has been used:
<list list-type="bullet" id="L12"><list-item><p id="P86"><italic toggle="yes">in psychiatry</italic>, for learning about genetic risks for ADHD [<xref rid="R36" ref-type="bibr">36</xref>].</p></list-item><list-item><p id="P87"><italic toggle="yes">in clinical psychology</italic>, for studying familiality and heritability of depression subtypes [<xref rid="R37" ref-type="bibr">37</xref>] <italic toggle="yes">and</italic> for studying the familial transmission of mania and depression [<xref rid="R38" ref-type="bibr">38</xref>].</p></list-item></list></p></list-item><list-item><p id="P88"><bold>To examine classification systems or diagnostic criteria.</bold> For example, it has been used:
<list list-type="bullet" id="L14"><list-item><p id="P89"><italic toggle="yes">in clinical psychology</italic>, for evaluating the DSM criteria for hoarding disorder [<xref rid="R39" ref-type="bibr">39</xref>].</p></list-item><list-item><p id="P90"><italic toggle="yes">in psychiatry</italic>, for examining a DSM alternative model for personality disorders [<xref rid="R40" ref-type="bibr">40</xref>] <italic toggle="yes">and</italic> for comparing DSM-IV and &#x02014; 5 criteria of autism spectrum disorders [<xref rid="R41" ref-type="bibr">41</xref>].</p></list-item></list></p><p id="P91">Description of an example study including a best-estimate assessment</p><p id="P92">Best-estimate assessments have, for example, been established to evaluate the validity of the Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime version (K-SADS-PL; a semi-structured diagnostic interview used in child and adolescent psychiatry [<xref rid="R42" ref-type="bibr">42</xref>]). The best-estimate assessments were diagnoses of neurodevelopmental and related disorders made by five experienced child psychiatrists based on the DSM-5 criteria. To achieve best-estimate assessments, patients were followed for at least three months, and the psychiatrists had access to all available data (except for the K-SADS-PL diagnoses), including information from medical records, interviews, questionnaires, laboratory tests, as well as information provided by clinical staff, caregivers and teachers. Criterion validity of the K-SADS-PL was established as the agreement of the diagnoses with the best-estimate assessments.</p></list-item></list></boxed-text></floats-group></article>